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 Bovine herpes virus 1 (BHV-1) is a significant viral pathogen in cattle that 
induces a myriad of clinical symptoms.  These symptoms include: conjunctivitis, upper 
respiratory tract infections, genital disorders, and abortions. BHV-1 infection can also 
lead to transient immune-suppression, which predisposes cattle to secondary bacterial 
infection leading to life-threatening pneumonia referred to as bovine respiratory disease 
(BRD). Following acute infection, BHV-1 establishes latency in sensory neurons within 
trigeminal ganglia. Reactivation of the virus can occur periodically, resulting in virus 
transmission. The latency-related (LR) RNA is the only abundantly expressed transcript 
in latently infected sensory neurons and it encodes several proteins, including ORF2, as 
well as two micro-RNAs. My dissertation work has focused on trying to understand how 
the LR gene is able to promote establishment and maintenance of latency, specifically 
through elucidating the mechanism of function of the LR encoded protein ORF2. ORF2 
inhibits apoptosis and also interacts with Notch signaling receptors, inhibiting their 
ability to activate certain BHV-1 promoters and enhance productive infection. The 
studies presented here identified, through mutational analysis, distinct domains in ORF2 
that regulate its stability, localization, and functional properties. Furthermore, ORF2 is 
able to affect different cellular processes and promote a mature neuronal phenotype 
through inhibition of the Notch pathway. Lastly, a subset of ORF2 was associated with 
chromatin and preferentially associated with single stranded DNA. Collectively, these 
studies suggest that ORF2 by interfering with apoptosis and the Notch pathway and 
through its ability to bind DNA plays a role in regulating certain aspects of the latency-
reactivation cycle. ORF2, in general, enhances survival of infected neurons, promotes a 
mature neuronal phenotype and consequently increases the pool of latently infected 
neurons. 
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INTRODUCTION 
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LITERATURE REVIEW 
 
I. Family Herpesviridae 
The Herpesviridae family members have been detected in most animal species, 
including essentially all mammals (Roizmann et al. 1992). All members share common 
structural traits as well as similar characteristics in their lifecycle. 
Herpesviruses do however display differences among each other in the 
composition and architecture of their genome, host range, growth characteristics, tissue 
tropism, duration of infection, cytopathology, and latency (Roizman et al. 1981). Based 
on these biological properties, herpesviruses are grouped into three subfamilies; 
Alphaherpesvirinae, Betaherpesvirinae and Gammaherpesvirinae (Roizman et al. 2001). 
Prototypes for each subfamily are, Human simplex virus type 1 (HSV-1), 
Cytomegalovirus (CMV) and Epstein-Barr virus, respectively. Alphaherpesvirinae are 
characterized by a variable host range, a relatively short replication cycle, rapid spread in 
culture, high cytopathicity, and ability to establish latency in sensory ganglia. In contrast, 
Betaherpesvirinae have a restricted host range, long reproductive cycle and slow progress 
of infection during which the infected cells become enlarged before lysis. In vivo, they 
establish latency in macrophages of the lymphoreticular tissues, kidneys and secretory 
glands for example. One of the major health concerns with beta-herpesviruses is CMV-
post transplantation infections. Gammaherpesvirinae, similar to the beta subfamily 
exhibit restricted host range. B and T lymphocytes are the primary target of infection 
although in vitro studies have shown that some types of epithelial cells and fibroblasts 
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can support viral replication. Latent virus is detected in lymphoid tissue and the typical 
outcome of infection is cell transformation (Roizman et al. 1991; Roizman et al. 2001).  
Herpesviruses possess linear double-stranded DNA genomes (∼130–250 kbp) and 
a complex architecture of infectious particles containing around 35 viral proteins, which 
are involved in nucleic acid metabolism, DNA synthesis, and protein processing. 
Herpesvirus genomes encode between 70 to 200 genes resulting in approximately 84 
different gene products. Although they differ greatly in terms of genomic sequence, 
Herpesviruses have similar virion structures and genomic organization. Herpesvirus 
genomes are usually organized as unique long or short regions bounded by inverted 
repeats. The average size of the virion is 180–200 nm in diameter and consists of a highly 
ordered icosahedral-shaped nucleocapsid of about 125–130 nm in diameter which 
encases the genome.  The nucleocapsid is surrounded by an amorphous proteinaceous 
layer called the tegument, which in turn is enclosed within the host-derived envelope 
containing multiple copies of more than 10 different kinds of viral glycoproteins that are 
responsible for viral attachment and entry to host cells (Armstrong et al. 1961; Jones 
1998; Tikkoo et al. 1995). Both viral replication and assembly occur in the nucleus of the 
host cell (Roizman et al. 2001). 
 
II. Bovine Herpesvirus type 1 (BHV-1) 
Bovine herpesvirus type 1(BHV-1) is a member of the Alphaherpesvirinae 
subfamily further classified within the varicellovirus genus (Brown 1989; Roizman et al. 
2001). The BHV-1 genome is 135.3 kilobase pairs (kbp) with a high guanine and 
cytosine (GC) content arranged as a class D herpesvirus genome (Figure 1.1A) (Plummer 
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et al. 1969). Class D genomes contain a unique long (UL, 104 kbp) and a unique short 
(US, 10 kbp) region which is flanked on both sides by long and short inverted internal 
(IRL and IRS) and long and short terminal repeats (TRL and TRS) each consisting of 11 
kbp (Muylkens et al. 2007) (Figure 1.1A). A total of 73 open reading frames (ORFs) 
have been identified so far and the majority of the BHV-1 genes consist of ORFs that are 
homologous to genes found in other alpha-herpesviruses and have been generally  named  
to the related genes in the prototype HSV-1 (Muylkens et al. 2007). 
All BHV-1 strains isolated belong to one single viral species and are classified 
into three subtypes based on antigenic and genomic analysis, BHV-1.1, 1.2a, 1.2b 
(Metzler et al. 1985). Subtype 1 virus isolates are the causative agent for infectious 
bovine rhinotracheitis (IBR) and are typically found in the respiratory tract and in aborted 
fetuses. Subtype 1 strains are common in Europe, North and South America. Subtype 2a 
is associated with a broad range of clinical symptoms in the respiratory and genital tract 
like infectious pustular vulvovaginitis (IPV) and balanopostitis (IPB) and abortions (van 
Oirschot 1995). Its prevalence is in Brazil and in Europe before 1970 (van Oirschot 
1995). Subtype 2b is also associated with respiratory disease, IPV and IPB but not with 
abortions and has been isolated in Australia and Europe (D'Arce et al. 2002; van Oirschot 
1995). 
 
II. A. Pathogenesis 
 Herpesviruses share many biological traits across family members including a 
number of homologous proteins, production of viral progeny that leads to host cell lysis 
and most importantly the ability to persist in a “latent” state inside the host. However, 
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certain biological aspects of disease vary greatly, for example host range, length of 
productive infection, and tissues where a latent infection occurs. 
 Natural infection of BHV-1 occurs by contact of the virus with mucosal 
membranes of either upper respiratory or genital tracts of cattle  although, there has been 
one report of BHV-1 virus present in insect vectors (Taylor et al. 1982). Virus entry into 
the respiratory tract can occur via aerosol or by direct contact with virus present in nasal 
secretions (Mars et al. 2000). In contrast, genital transmission requires direct contact at 
mating or through semen containing virus (Kupferschmied et al. 1986). Infection can also 
be transmitted through inoculation of the conjunctival epithelium.  
 There are several factors that can influence the clinical symptoms and severity of 
the disease caused by BHV-1: virulence of the strain, type of tissue infected, resistance 
factors of the host, age of the host, and secondary bacterial infection. There are two major 
syndromes associated with BHV-1 infections: (i) Infectious bovine rhinotracheitis (IBR), 
which occurs in the respiratory tract, and (ii) infectious pustular vulvovaginitis (IPV) (in 
cows) and balanoposthitis (in bulls), which occurs in the genital tract.  
 IBR is associated with clinical symptoms such as pyrexia, apathy, increased 
respiratory rate with persistent harsh cough and anorexia, while adult dairy cows exhibit a 
severe drop in milk production. Mucopurulent discharge from the nostrils and eyes is 
associated with pustular lesions in the nasal mucosa and conjunctivitis. The nasal and 
tracheal turbinates are areas primarily involved (Jones et al. 2007; Jones et al. 2010; 
Muylkens et al. 2007).  
 BHV-1 is also one of the major etiological agents of bovine respiratory disease 
complex (BRDC) commonly known to the cattle industry as the “shipping fever” (Jones 
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et al. 2010). Since BHV-1 is immunosuppressive, infection can lead to secondary 
bacterial infection by opportunistic pathogens such as Pasteurella haemolytica, 
Pasteurella multocida, and Histophilus somni which leads to pneumonia (Babiuk et al. 
1988; Griffin et al. 2010; Yates 1982). Approximately 75% of morbidity and 50% of 
mortalities in feedlot cattle are attributed to BRDC amounting to ~$ 2 billion annual 
losses making BRDC the most economically significant disease to the cattle industry 
(Kapil et al. 1997; Powell 2005).  
 Other diseases observed are abortions (due to fetal death), fatal multisystemic 
infection of newborn calves, meningoencephalitis, mastitis, enteritis (Kahrs 1977; Lupton 
et al. 1980). IPV syndrome is mainly associated with pustular lesions of the genital tract 
and does not lead to as a severe a disease as IBR, but it is still a cause of concern 
(Wittmann 1989). 
 Control measures for the eradication of BHV-1 have relied on serological testing 
of animals and removal of the seropositive individuals. This approach however can be a 
daunting task in countries like United States due to the large numbers of animals, the 
constant movement of herds, and feedlot conditions where large numbers of animals 
reside in fairly tight quarters. Several modified live vaccines have been developed, 
however they have the ability to establish latency, and can be pathogenic to young calves 
and cause abortions (Thiry et al. 1985; van Drunen Littel-van den Hurk et al. 1993). 
Another problem associated with these vaccines is the inability to detect a naturally 
infected versus a vaccinated cow. The goal remains to develop a vaccine that can induce 
a robust immune response, be able to be distinguished from wild type (wt), and perhaps 
protect against wt virus becoming latent. 
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II.B. Productive infection 
II. B. 1. Overview 
 BHV-1 infection of permissive cells starts with the entry process which is divided 
into three steps. First a low affinity interaction occurs between gB and/or gC to cell 
surface structures like heparin sulfate sugar moieties (Li et al. 1995; Liang et al. 1992; 
Liang et al. 1991; Okazaki et al. 1994). The initial low affinity interaction facilitates the 
stable binding of gD to cellular specific receptors. There are several potential candidates 
however, only nectin-1 has been shown to act as an entry receptor for BHV-1 (Geraghty 
et al. 1998). After the high affinity interaction fusion of the virion envelope and the 
plasma membrane occurs releasing the de-enveloped nucleocapsid into the cytoplasm 
(Campadelli-Fiume et al. 2007). Once in the cytosol, virus nucleocapsids most likely 
piggyback the dynein motor complexes associated with microtubules to the nucleus to 
release the DNA (Dohner et al. 2002). In the nucleus, BHV-1 gene expression is 
regulated in a temporal fashion giving rise to successively immediate early (IE), early 
(E), and late (L) RNA. These transcripts encode proteins involved in the regulation of 
viral transcription, viral DNA replication, and morphology of progeny virions 
respectively. The mature virions are assembled in the nucleus. It is not clear how the 
virions escape the nucleus to enter secretory vesicles and how this virus particle acquires 
its envelope is controversial. The current accepted model proposes budding of capsids 
through the nuclear inner membrane which provides the primary envelope. To be 
released in the cytoplasm, virions fuse their primary envelope with the outer nuclear 
membrane. Once released in the cytoplasm, naked capsids acquire their tegument and 
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their secondary envelope by travelling through the Golgi apparatus and secretory 
pathway.  As with all alpha-herpesviruses, production of new progeny virus apparently 
results in cell death (Muylkens et al. 2007). 
 
II. B. 2. Viral gene expression 
 Once BHV-1 enters the nucleus of a permissive cell, the lytic replication cycle 
begins. Viral gene expression can be divided into three distinct phases, which leads to 
production of progeny virus and ultimately cell death. In bovine primary cell cultures, 
BHV-1 DNA synthesis starts within the first two hours post infection (h pi) and peaks at 
4-6 h pi (Ghram et al. 1986). Viral proteins can be detected as early as 4 h pi and peak at 
6-8 h pi (Ghram et al. 1986). IE genes (bICP0, bICP4, bICP22, and bcirc) are expressed 
in the first 2 h pi and do not require de novo protein expression. E gene transcription 
occurs 2-4 h pi and requires IE proteins, but not viral DNA synthesis (Schwyzer et al. 
1996; Tikkoo et al. 1995). L gene transcription occurs 6-8 h pi and is dependent on viral 
protein and DNA synthesis (Seal et al. 1992). Gamma 1 genes are transcribed at low 
levels even when viral replication is blocked. Gamma 2 genes are dependent on viral 
replication. IE gene expression is stimulated by the tegument protein BHV-1 alpha-
transactivating factor (bα-TIF), which is a homologue of the HSV-1 VP16. Bα-TIF 
associates with the cellular transcription factor Oct-1 and activates IE gene expression by 
interacting with the TAATGAGCT sequence present in all BHV-1 IE gene promoters 
(Dixon et al. 1980; Misra et al. 1994). There are two IE transcription units: IE 
transcription unit 1 (IEtu1) and IEtu2 (Figure 1.1B) (Misra et al. 1994; Misra et al. 1995). 
IEtu1 encodes functional homologues of two HSV-1 IE proteins, infected cell protein 0 
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(bICP0) and ICP4 (bICP4). Circ, is also encoded by IEtu1 and it is a less abundant 
transcript that encodes a tegument protein and is expressed throughout the viral cycle 
(Fraefel et al. 1994; Fraefel et al. 1993). IEtu2 encodes a protein homologous to HSV-1 
ICP22 (bICP22). The IE proteins have transcriptional regulatory functions. bICP4 and 
bICP22 inhibit IEtu1 and IEtu2 expression while activating E and L gene promoters 
(Schwyzer et al. 1993). bICP0, although not essential, plays an important role during 
productive infection because it can activate all three classes of viral promoters (Wirth et 
al. 1992) and it is expressed at high levels throughout infection (Everett 2000; Fraefel et 
al. 1994). The E genes encode proteins involved in DNA synthesis while L genes encode 
structural proteins and their synthesis culminates in virion assembly and release. 
 
II. C. Latency-Reactivation Cycle 
II. C. 1. Overview  
The lytic phase of BHV-1 lifecycle produces many virions at the mucosal surface 
of the initial infection. BHV-1 mature virions can gain access to sensory nerve terminals 
that innervate the mucosal tissue through cell to cell spread (Enquist et al. 1999). The 
virus is then transported along the microtubules of axons in a retrograde direction to the 
neuron body in the nervous ganglion (Tomishima et al. 2001). If the infection is initiated 
via the oral, nasal cavities or ocular surface, the primary site for latency is sensory 
neurons within the trigeminal ganglia (TG) (Jones et al. 2010). Although the main site of 
latency for BHV-1 is TG sensory neurons, evidence suggests that latent infection can also 
occur in non-neuronal sites like lymphoid follicles and pharyngeal tonsils (Winkler et al. 
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2000), peripheral blood cells (Fuchs et al. 1999), and lymph nodes and spleen (Mweene 
et al. 1996).  
 In contrast to productive infection (lytic phase) where all viral genes are 
expressed, the hallmarks of a latent infection are minimal viral gene expression, absence 
of lytic cycle viral proteins, and the absence of virus production. The viral genome is 
maintained as an episome while promoting survival of the latently infected cell. Latently 
infected cells represent a pool of virus that can escape the surveillance of the host 
immune system while periodically reactivating, facilitating transmission and making 
herpesviruses very successful in nature.  
The latency-reactivation cycle has been divided into three operational steps: 
establishment, maintenance, and reactivation. These steps are discussed in detail below. 
 
II. C. 2. Establishment of latency 
 Extensive viral gene expression and replication occur within TG for 
approximately one week following infection of calves with BHV-1 (Schang et al. 1997; 
Winkler et al. 2000). Around 7 days post infection (dpi) lytic viral gene expression is 
extinguished. Inhibition of IE gene expression leads to reduced cellular toxicity and 
productive infection, tipping the balance toward the establishment of latency. Neurons 
that survive retain viral genomes as episomes associated with nuclear histones (Rock et 
al. 1983; Rock et al. 1985). Productive replication within the TG increases the number of 
latently infected neurons; however, replication is not required for establishment of 
latency because mutant viruses that cannot replicate establish latency but at reduced 
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levels (Coen et al. 1989; Efstathiou et al. 1989; Katz et al. 1990; Margolis et al. 1992; 
Sedarati et al. 1993; Steiner et al. 1990).  
 The host immune system contributes to the establishment of latency by 
suppressing infection and limiting the spread of the virus at the synaptic junctions. 
During acute infection in TG there is an infiltration of immune cells by 7-10 dpi and an 
increase of interferon-gamma (IFN-γ) and interleukin 4 (IL-4) expression (Erturk et al. 
1992; Liu et al. 1996; Shimeld et al. 1995; Stumpf et al. 2001; Winkler et al. 2002). The 
presence of immune cells in close proximity of infected neurons strongly suggests that 
the immune system promotes the establishment of latency by inducing a non-permissive 
environment. This role is also supported by evidence that IFN-γ, tumor necrosis factor 
alpha (TNF-α), and CD8+ T-cells repress productive infection (Cantin et al. 1999; Cantin 
et al. 1999; Cantin et al. 1995; Halford et al. 1996). The cytokine environment may also 
promote latency by influencing neuronal health.  
 Another important factor in the establishment of latency is LR gene expression. 
LR gene products promote latency by repressing lytic gene expression (Bratanich et al. 
1992; Geiser et al. 2002; Jaber et al. 2010) and inhibiting apoptosis in latently infected 
neurons (Ciacci-Zanella et al. 1999; Henderson et al. 2004; Lovato et al. 2003; Shen et 
al. 2008; Sinani et al. 2011) (Discussed in more detail later). 
 
 II. C. 3. Maintenance of latency 
 Maintaining a successful latent infection requires that the viral genome be 
preserved within the infected cell and that the cell remain alive. Since neurons are non-
dividing cells, genome replication and division to daughter cells is not a concern for 
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alpha-herpesviruses. The genome is maintained as a nucleosomal, circular episome 
associated with histones. To avoid induction of apoptosis and/or immune detection 
expression of viral genes, normally required for productive infection, is extinguished. The 
LR gene is the major player in the maintenance of latency.  
 
II. C. 4. Reactivation from latency 
 Reactivation from latency is usually triggered by external stimuli like stress or 
immunosuppression. Transporting cattle from one location to another or weaning of 
young calves are well known stressful events, which may lead to reactivation events. A 
single injection of the synthetic corticosteroid dexamethasone (DEX) induces reactivation 
of BHV-1 in latently infected rabbits and cows 100% of the time (Davies et al. 1973; 
Homan et al. 1983; Inman et al. 2002; Rock et al. 1992; Sheffy et al. 1972). Virus is 
present in ocular secretions or TG homogenates from rabbits between 48 and 72 hours 
after DEX treatment. Within 18 hours after DEX treatment expression of all classes of 
viral genes can be detected in approximately 20% of neurons in TG (Rock et al. 1992). 
BHV-1 specific neutralizing antibodies in the serum increase significantly after treatment 
with DEX, which correlates with reactivation (Homan et al. 1983).  
 DEX-induced reactivation is biologically relevant because naturally occurring 
stress increases corticosteroid levels enhancing viral replication and virus shedding 
(Sheffy et al. 1972; Wyler et al. 1989). In a BHV-1 latently infected rabbit model, DEX-
mediated reactivation lead to a decrease of LR gene expression in sensory neurons (Rock 
et al. 1992). DEX treatment also affects splicing patterns in the absence of protein 
synthesis and induces expression of cyclin A which is required for cell cycle progression 
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(Collett et al. 1993; Schang et al. 1996). Cell cycle progression is beneficial to the lytic 
phase of herpesviruses. Although repeated injections with high levels of DEX can lead to 
immunosuppression, (Migliorati et al. 1994; Schmidt et al. 1999; Winkler et al. 2002), it 
is more likely that DEX triggers reactivation in TG by activating viral and host gene 
expression. 
 
II. C. 5. Latency related gene 
 In contrast to the 70-80 genes that are expressed during productive infection, LR-
RNA is the only abundantly expressed transcript during latency (Kutish et al. 1990; Rock 
et al. 1992; Rock et al. 1987). In situ hybridization localizes LR-RNA to the nucleus of 
the latently infected neurons (Kutish et al. 1990; Rock et al. 1987). The full LR gene is 
approximately 2 kbp long (980 bp of promoter and 1180 bp of transcribed region) and it 
is transcribed antisense to the bICP0 mRNA (Jones et al. 1990; Kutish et al. 1990). In 
situ hybridization studies mapped the start site of the LR transcription between 
nucleotides (nts) 700 and 981 (Liang et al. 1992; Rock et al. 1992). The start site for lytic 
expression was identified to be at nt 724 which is 24 nts downstream of the AT-rich 
sequences resembling TATA boxes (Figure 1.2B) (Bratanich et al. 1992). A different 
start site utilized during latency was determined to reside 200-300 bps upstream of the 
lytic site (Hossain et al. 1995).  
The promoter of the LR gene is contained within the 980 bp PstI fragment and it 
is down-regulated by DEX (Figure 1.2B) (Jones et al. 1990). The LR promoter has strict 
orientation, and it is more active in bovine and neuronal cell lines versus non-bovine, 
non-neuronal ones (Bratanich et al. 1992; Jones et al. 1990). Studies have also suggested 
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that tissue and species-specific transcription factors may play a role in the regulation of 
the LR-gene expression (Delhon et al. 1997).  
A small fraction of the LR transcripts in TG are alternatively spliced and 
polyadenylated, suggesting these transcripts may be translated into more than one LR 
protein (Devireddy et al. 1998; Hossain et al. 1995). LR gene products inhibit S phase 
entry by interacting with cyclin dependent kinase 2 (cdk2)/cyclin complexes and also 
promotes cell survival following induction of apoptosis (Ciacci-Zanella et al. 1999; Jiang 
et al. 1998; Schang et al. 1996). The LR gene sequence includes two well defined open 
reading frames (ORFs) (ORF1 and 2) and two reading frames lacking an initiating ATG 
(RF-B and C) (Figure 1.2A). Splicing at 1 dpi in TG leads to expression of intact ORF2 
(Devireddy et al. 2003; Devireddy et al. 1998). ORF2 coding sequences due to 
alternative splicing can be fused at the C-terminus with ORF1 or RF-B coding sequences 
at 7 and 15 dpi respectively (Devireddy et al. 2003; Devireddy et al. 1998).  
 When expressed in the absence of other viral genes, ORF2 inhibits cold shock-
induces apoptosis in certain neuroblastoma cells (Shen et al. 2008). A protein resulting 
from the fusion of ORF2 with ORF1 interacts with two pro-apoptotic proteins (Bid and 
Cdc42) suggesting a possible mechanism for inhibition of apoptosis (Meyer et al. 2007). 
Moreover, the ORF2/ORF1 fusion protein (7dpi) interacts with the cellular transcription 
factor CAAT/enhancer binding protein (C/EBP) alpha (Meyer et al. 2007). C/EBP alpha 
activates the expression of bICP0, the main BHV-1 viral trans-activator (Workman et al. 
2009). This is biologically significant because ORF2, whether in its intact form or fused 
with ORF1, could potentially promote establishment and maintenance of latency by 
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inhibiting apoptosis and interfering with cellular transcription factors that enhance 
productive infection.  
 A mutant BHV-1 virus designed with three stop codons at the N-terminus of 
ORF2 (LR mutant virus) is unable to express ORF2 or RF-C but can express low levels 
of ORF1 (Inman et al. 2001; Jiang et al. 2004; Meyer et al. 2007). Infection of calves 
with the LR mutant virus results in reduced virus shedding in ocular tissue, TG, and 
tonsils plus the LR mutant virus does not reactivate from latency following treatment 
with DEX (Inman et al. 2001; Inman et al. 2002; Perez et al. 2005). LR mutant virus also 
induces higher levels of apoptosis in TG of infected calves when compared to wt or 
rescued BHV-1 suggesting that a protein encoded by the LR gene protects neurons from 
cell death during the establishment and maintenance of latency (Lovato et al. 2003).  
 Even though studies from our lab have clearly underlined the importance of 
proteins encoded by the LR gene, recent evidence provides evidence that non-protein 
coding LR-RNA regulates certain aspects of the latency-reactivation cycle (Bratanich et 
al. 1992; Geiser et al. 2002; Jaber et al. 2010). LR gene inhibits bICP0 activation of 
BHV-1 productive infection in a dose-dependent manner. Insertion of three stop codons 
at the amino-terminus of the first ORF in the LR gene (ORF2) did not rescue bICP0 
inhibition suggesting that LR proteins were not required for this inhibition (Geiser et al. 
2002). The expression of the LR transcript is antisense to bICP0 and hybridization of LR-
RNA sequences with bICP0 mRNA has been proposed as a possible mechanism for this 
inhibition. However, there is no experimental evidence that this is the case. LR gene 
products also inhibit mammalian cell growth (Geiser et al. 2005; Schang et al. 1996). 
Both of these inhibitory functions of the LR gene have been mapped to a 463-bp XbaI-
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PstI region (XP) (Geiser et al. 2002; Seal et al. 1992; van Drunen Littel-van den Hurk et 
al. 1993). A recent study in our lab demonstrated that this region has the potential to form 
stem-loop secondary structures and it gives rise to two families of small non-coding 
RNAs (sncRNAs) (Jaber et al. 2010). These sncRNAs are precursors that mature into two 
micro RNAs (miRNAs), which are expressed in the TG of latently infected calves where 
they promote latency by inhibiting bICP0 expression and productive infection.  
 LR gene products may also promote latency by inhibiting the host IFN-β 
response. The LR mutant virus expresses LR-RNA prematurely relative to wt or the LR 
rescued virus leading to higher IFN-β expression during productive infection of bovine 
cells in in vitro cultures as well as in the tonsils of calves during lytic infection (Perez et 
al. 2008). This, along with increased apoptosis in the TG of calves infected with the LR 
mutant virus may be the reason why this mutant virus exhibits diminished symptoms and 
fails to reactivate from latency (Inman et al. 2001; Inman et al. 2002; Perez et al. 2005).  
 
III. BHV-1 evasion of the immune system 
III. A. Overview 
 Following primary infection of cattle with BHV-1, cattle mount a robust immune 
response and for the most part inhibit virus shedding and recovery from disease occurs. 
However, infected cattle are never able to completely clear BHV-1 and the virus 
establishes a life-long latent infection.  
BHV-1 employs numerous immune evasion strategies. Studies published from our 
lab have shown that BHV-1 interferes with innate immunity because bICP0 inhibits 
transcription of type I IFN by inducing proteasome-dependent degradation of interferon 
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regulatory factor 3 (IRF3) and by a direct interaction with IRF7 (Henderson et al. 2005; 
Saira et al. 2009; Saira et al. 2007). Both IRF3 and 7 are proteins involved in a regulatory 
complex responsible for activating transcription of type I IFN. Another strategy 
employed by BHV-1 to avoid innate immune response is through interaction of 
glycoprotein C (gC) with the third complement component (C3) which is the key 
activator of the complement system (Huemer et al. 1993). Innate immunity is also 
impacted by a conserved alpha-herpesvirus immunomodulatory function through the 
interaction of gG with several chemokines preventing recruitment and activation of 
several innate immunity cells (Bryant 2003; Costes et al. 2005). Evading the innate 
immunity enables an efficient replication of the virus during productive infection. 
 Several strategies are geared towards avoiding detection by cell mediated 
immunity. During acute infection, BHV-1 down-regulates antigen presentation by class I 
and class II major histocompatibility complexes (MHC class I and II) (Hinkley et al. 
2000; Hinkley et al. 1998; Koppers-Lalic et al. 2005; Koppers-Lalic et al. 2001; Lipinska 
et al. 2006; Nataraj et al. 1997). This is achieved through UL49.5 by blocking the 
transporter associated with antigen processing (TAP) and through virion host shutoff 
protein (vhs, encoded by UL41) by reducing MHC class I and II mRNA. 
 BHV-1 also impairs CD4
+
 T-cell responses because it infects them and induces 
apoptosis during productive infection (Winkler et al. 1999). Apoptosis is presumably 
induced through activation of caspases and p53 (Devireddy et al. 1999). 
 As mentioned earlier, these strategies enable efficient replication of BHV-1 
during the acute phase. However, the host immune system clears productive infection and 
virus shedding at the initial site of infection. The immune system is unable to prevent 
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establishment and maintenance of latency. During latency, evidence suggests that BHV-1 
subverts the immune system possibly by stimulating certain immune factors in order to 
create a milieu that favors latency. Infection of mice with HSV-1 or cattle with BHV-1 
shows infiltration and persistence of immune cells in the TG during latency (Allen et al. 
2011; Cantin et al. 1995; Halford et al. 1996; Perez et al. 2006; Shimeld et al. 1995; 
Winkler et al. 2002). This evidence suggests that the presence of the immune system in 
close proximity with infected neurons promotes establishment and maintenance of 
latency by inducing a non-permissive environment. 
 
III. B. Apoptosis 
 Apoptosis is one form of programmed cell death (PCD), and a natural and 
essential process in the development and maintenance of multicellular organisms. 
Apoptosis exhibits morphological characteristics like chromatin condensation (pyknosis), 
fragmentation of the nucleus (karyorhexis), nucleosomal laddering of the DNA, 
membrane blebbing and the formation of apoptotic bodies (Danial et al. 2004; Fesik et al. 
2001; Kerr et al. 1972; Werlen et al. 2003). Apoptosis is indispensable for maintaining 
healthy organs and tissues because it eliminates old or unhealthy cells. On the other hand 
if left unchecked, apoptosis can lead to tissue damage, which has been linked to 
neurodegenerative disorders like Alzheimer’s, Huntington’s and Parkinson’s diseases.  
 PCD is triggered by a variety of controlled external and internal stimuli which 
differentiates it from necrotic death (Elward et al. 2003). Apoptosis differs from necrosis 
also by the manner with which the cellular debris is disposed of. In necrosis, cleanup by 
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the immune cells leads to an inflammatory response, while during apoptosis cleanup is 
mediated by immune cells through phagocytosis without triggering inflammation. 
 There are two fundamentally distinct stimuli that lead to apoptosis; extrinsic 
(extracellular) and intrinsic (intracellular). Extrinsic stimuli include hormones, growth 
factors, toxins, cytokines, and nitric oxide. The intrinsic pathway can be stimulated by 
signals from abnormal physiological stresses as a result of nutrient deprivation, oxidative 
stress, radiation, and viral or bacterial infection. 
 Two ligands that trigger the extrinsic pathway are tumor necrosis factor (TNF) 
and the Fas-Fas ligand (FasL). Both are type II transmembrane proteins and members of 
the TNF family. TNF binds to the TNF receptor (TNFR) while FasL binds to Fas receptor 
(FasR), also known as apoptosis antigen 1 (APO-1) or cluster of differentiation 95 
(CD95), which results in apoptosis (Chen et al. 2002; Hsu et al. 2005). Binding of TNF 
to TNFR activates apoptosis by recruiting TNF receptor-associated death domain 
(TRADD) and caspase 8 to form caspase 8 activating complexes (Wang et al. 2008). 
Binding of FasL to CD95 recruits Fas-associated death domain (FADD) which further 
recruits caspases 8 and 10 and c-FLIP(L), to form a death-inducing signaling complex 
(DISC). DISC formation leads to activation of caspase 8 and caspase 10 which are 
released to the cytoplasm where they activate caspase 3. Activation of caspase 3 is 
considered the point of no return. TNF-related apoptosis-inducing ligand (TRAIL) which 
shows homology to other members of the TNF superfamily can also induce apoptosis 
(Thorburn 2004). TRAIL binds to death receptors (DRs) 4 and 5 triggering caspase 8-
mediated apoptosis. 
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 The intrinsic pathway involves mitochondrial membrane permeabilization 
(MMP), which leads to release of apoptotic effectors (Dejean et al. 2006). The main 
effector is cytochrome c, which is released into the cytoplasm through the mitochondrial 
apoptosis-induced channel (MAC) (Dejean et al. 2006). Cytochrome c binds to apoptotic 
protease activating factor 1 (Apaf 1) and dATP, which recruits caspase 9 forming the 
apoptosome complex. This leads to activation of caspase 9 which in turn activates 
caspase 3 leading to apoptosis (Fesik et al. 2001). 
 Members of the Bcl-2 family of proteins are involved in the regulation of the 
intrinsic apoptotic pathway by controlling formation of MAC (Chao et al. 1998; Dejean 
et al. 2006; Dejean et al. 2006). The family includes members that are both pro and anti-
apoptotic. For example, Bax and/or Bak expression leads to induction of apoptosis while 
Bcl-2 and Bcl-xL inhibit apoptosis possibly by inhibiting Bax/Bak. 
 
III. C. Viral modulation of apoptosis 
 Many viruses are known to induce apoptosis when infecting cells in vitro and in 
vivo (Hardwick 1998; Razvi et al. 1995). Killing of infected cells by apoptosis can be 
beneficial to viral infection in vivo, because it reduces inflammation, inhibits immune 
recognition, and facilitates cell to cell spread (Teodoro et al. 1997). On the other hand, 
premature apoptosis induction by the infected host cell is a strategy to eliminate infected 
cells and inhibit viral replication. Therefore it is imperative for viruses to modulate 
apoptosis in order to utilize this cellular process for their benefit. Viral specific proteins 
modulate the apoptotic response typically through the mitochondria (intrinsic pathway) 
(Boya et al. 2004; Galluzzi et al. 2008). Viral apoptotic modulators can be pro and anti-
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apoptotic. Pro-apoptotic viral proteins induce apoptosis by increasing MMP, either by 
inserting into the mitochondrial membranes to facilitate MMP or by activating certain 
host factors that induce MMP. On the other hand, viral anti-apoptotic modulators inhibit 
apoptosis: many by mimicking Bcl-2 homologues.  
 Members of the alphaherpesvirinae subfamily induce apoptosis during productive 
infection (Delhon 2002; Devireddy et al. 1999; Galvan et al. 1999; Galvan et al. 1998; 
Sadzot-Delvaux et al. 1995). HSV-1 can induce or inhibit apoptosis in a cell-type 
dependent manner after infection of cultured cells (Asano et al. 1999; Aubert et al. 1999; 
Galvan et al. 1999; Galvan et al. 1998; Leopardi et al. 1996). HSV infection leads to 
induction of apoptosis by possibly several mechanisms. For example, HSV induces DNA 
damage even in the absence of productive infection (Chenet-Monte et al. 1986; 
Heilbronn et al. 1989; Schlehofer et al. 1982). DNA damage is a potent apoptosis inducer 
(Soengas et al. 1999). Two viral proteins US1.5 and UL13 when expressed in the absence 
of other viral proteins have the potential to activate caspase 3 although the mechanism of 
activation is not clear (Hagglund et al. 2002). Several anti-apoptotic genes within the 
HSV-1 genome have been identified (Ahmed et al. 2002; Asano et al. 1999; Aubert et al. 
1999; Blaho 2001; Galvan et al. 1999; Inman et al. 2001; Jerome et al. 2001; Jerome et 
al. 1999; Jerome et al. 1998; Munger et al. 2001; Munger et al. 2001; Perng et al. 2002; 
Perng et al. 2000). The anti-apoptotic genes include ICP27, US3, US5, gJ, gD, and LAT. 
ICP27 delays caspase 3 processing of the DNA fragmentation factor (DFF) and poly 
ADP-ribose polymerase (PARP). US3 is a viral protein kinase that blocks the cleavage 
and activation of the pro-apoptotic protein BAD. gJ inhibits cytotoxic T-lymphocyte 
(CTL) Granzyme B and Fas-induced apoptosis by protecting infected cells from DNA 
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fragmentation. gD can also prevent Fas-induced apoptosis by activating NF-κB. Lastly 
LAT seems to inhibit the splicing of Bcl-x into the short pro-apoptotic form while 
stabilizing the long anti-apoptotic version (Peng et al. 2003).  
 BHV-1 induces apoptosis in bovine peripheral blood mononuclear cells (PBMCs) 
and CD4
+
 T-cells in vitro (Devireddy et al. 1999; Eskra et al. 1997; Hanon et al. 1999; 
Hanon et al. 1997; Hanon et al. 1998; Hanon et al. 1996; Winkler et al. 1999). BHV-1 
can inhibit apoptosis through the expression of the LR gene. LR gene products block 
apoptosis in cultured cells and in neurons of infected calves (Ciacci-Zanella et al. 1999; 
Lovato et al. 2003). LR does this in part by preventing activation of caspase 3 and 9 
during productive infection (Henderson et al. 2004). Of particular interest to BHV-1 
infection is how apoptosis unfolds in neurons. In sympathetic neurons and differentiated 
PC12 cells, withdrawal of growth factors leads to induction of apoptosis. The initiators of 
apoptosis are small GTP-binding proteins Cdc42 and Rac1 (Bazenet et al. 1998; Estus 
1994), which signal through c-Jun N-terminal kinase and c-Jun, resulting in apoptosis 
(Xu et al. 2001). Inflammatory cytokines and environmental stresses such as UV 
radiation, heat shock, oxidative stress, hyperosmolarity, and axonal injury all trigger 
Cdc42 and JNK activation in neurons. Many of these stimuli also trigger reactivation of 
herpesviruses (Jones 2003). A recent study from our lab demonstrated that LR ORF2 and 
ORF2/ORF1 fusion proteins inhibited cold shock and/or FasL-induced apoptosis in 
mouse neuroblastoma cells and this inhibition was protein not mRNA dependent (Shen et 
al. 2008). Because ORF2/ORF1 fusion protein interacts with Bid and Cdc42 this suggests 
a possible mechanism of inhibition of apoptosis by the LR gene (Meyer et al. 2007). 
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IV. Notch signaling 
IV. A. Overview 
 The Notch pathway is a highly conserved signaling pathway that occurs between 
neighboring cells, and is one of the primary pathways by which organisms differentiate 
precursor cells into specialized tissues and organs. It is indispensable during embryonic 
development and is also essential for cell fate decisions in the adult organism (Artavanis-
Tsakonas et al. 1999). Additionally, Notch regulates cell proliferation, apoptosis, 
hypoxia, establishment of stem cell niche and stem cell renewal (Kimble et al. 2007; 
Morrison et al. 2006; Ruas et al. 2007). The Notch pathway is regulated at multiple 
levels; outside the cell, in the cytoplasm, and within the nucleus. Aberrant Notch 
signaling is linked to developmental disorders, cardiovascular defects and cancer 
(Gridley 2003; High et al. 2008; Miele et al. 2006). The core components of the pathway 
consist of a ligand DSL (Delta, Serrate, Lag-2), a receptor Notch and a transcription 
factor CSL (CBF1/RBP-Jκ, Su(H), Lag-1) (Bray 2006) (Figure 1.3). Both DSL (Delta, 
Serrate, Lag-2) and CSL (CBF1/RBP-Jκ, Su(H), Lag-1) are named for the mammalian, 
D. melanogaster, and C. elegans orthologous proteins, respectively. Organisms typically 
encode multiple Notch receptors and ligands, but only one CSL. Mammalians have four 
Notch receptors (Notch1-4) and five DSL ligands (Delta 1, 3, and 4, Jagged 1, 2) (Table 
1.1). Both the ligand and Notch receptor are multidomain type I transmembrane proteins 
while CSL is a DNA-binding transcription factor that acts both as a repressor and 
activator of Notch target genes. Upon binding of the ligand from a signal-sending cell to 
the receptor of a signal-receiving cell, the Notch receptor undergoes two sequential 
proteolytic cleavages. The first cleavage occurs extracellularly by the membrane-bound 
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metallo-protease TNFα-converting enzyme (TACE). The second cleavage is carried out 
inside the membrane by the γ-secretase complex. The result of the second cleavage 
releases the Notch intracellular domain (NICD) from the membrane into the cytoplasm. 
NICD contains nuclear localization signals that direct it to the nucleus where it forms a 
ternary complex with the DNA binding protein CSL and the transcriptional co-activator 
Mastermind (Petcherski et al. 2000; Petcherski et al. 2000; Tamura et al. 1995; Wu et al. 
2000). Formation of the CSL-Notch-Mastermind ternary complex is obligatory for the 
transcription of Notch target genes. 
 CSL is the conduit that ultimately converts the extracellular signal into a 
transcriptional one. In the absence of Notch signaling, CSL forms a repressor complex by 
interacting with the transcriptional machinery and by recruiting silencing mediator of 
retinoid and thyroid receptors (SMART)/nuclear receptor co-repressor (N-CoR), CBF1-
interacting co-repressor (CIR), and SMRT/HDAC-1-associated protein (SPEN or 
SHARP) (Hsieh et al. 1999; Kao et al. 1998; Olave et al. 1998; Oswald et al. 2002). The 
co-repressor complex recruits histone deacetylase complexes (HDACs) to the local 
chromatin and converts it to the transcriptionally silent configuration. NICD binding to 
CSL results in the release of the co-repressor complex and recruitment of Mastermind. 
The ternary complex NICD-CSL-Mastermind activates transcription through interaction 
with Histone acetyltransferase (HAT) complexes PCAF/GCN5 and CBP/p300 (Fryer et 
al. 2002; Kurooka et al. 2000; Wallberg et al. 2002). Concomitantly Mastermind also 
recruits specific kinases that hyperphosphorylate NICD resulting in ubiquitin-mediated 
proteasomal degradation, release of the co-activator complex, and once again repression 
of target genes (Fryer et al. 2004). 
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IV. B. Notch signaling in neuronal tissue 
 The Notch pathway as mentioned above is critical for organogenesis by regulating 
an array of cellular processes including stem cell self-renewal, cell fate determination, 
cellular differentiation and apoptosis. In the central nervous system (CNS), components 
of the signaling pathway are present not only during the embryonic stages, but also 
continuously present in the adult nervous system (Presente et al. 2001). During the entire 
lifetime, Notch signaling is involved with changes in the cellular architecture and 
function of the nervous system by controlling neurogenesis, growth of axons and 
dendrites, synaptic plasticity, and neuronal death.  
 In the developing nervous system the proliferation, differentiation, and survival of 
neural stem cells (NSCs) are essential processes designed to generate sufficient neurons 
to form neuronal circuits. The regulation of these processes directly controls architecture, 
function, and plasticity of the CNS. Activated Notch signaling in NSCs maintains these 
cells in a proliferating state (Zhong et al. 1997), while Numb, a protein that antagonizes 
Notch and inhibits the pathway, promotes cell cycle arrest and neuronal differentiation 
(Li et al. 2003). In this way, Notch signaling controls NSC self-renewal and cell fate 
specification.  
 Notch receptors and ligands are also expressed in cells of the adult nervous 
system suggesting this signaling pathway controls CNS plasticity (Presente et al. 2001). 
As neurons differentiate from progenitor cells, they rapidly grow neurites to form 
synapses with other neurons. Mature neurons are capable of neurite outgrowth and 
retraction, synapse formation or disassembly, and strengthening of existing synapses 
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(neurite remodeling) (Antonini et al. 1993; Carlisle et al. 2005; Trachtenberg et al. 2002; 
Yuste et al. 2001). Notch signaling plays a central role in this process. Activated Notch 
leads to inhibition of neurite growth or promotes their retraction, while inhibition of 
Notch signaling promotes neurite extension (Berezovska et al. 1999; Redmond et al. 
2000; Sestan et al. 1999). Modification of neurite morphology could also provide a 
mechanism by which activated Notch signaling enhances synaptic plasticity (Engert et al. 
1999; Maletic-Savatic et al. 1999). Long-term potentiation (synaptic plasticity) is widely 
assumed to be the main mechanism of memory formation. 
 
IV. C. Viral regulation of Notch signaling 
 Notch signaling is an important target of numerous viruses because it controls 
cellular processes that are crucial for the viral life cycle (Hayward 2004). In general, 
viruses affect the Notch signaling pathway by three separate mechanisms. One, viral 
proteins mimic components of the Notch pathway. Two, viral proteins interact with 
components of the Notch pathway to modulate it. Three, viral proteins activate the Notch 
pathway at the transcriptional level. Modulation of Notch pathway leads to activation of 
viral and cellular promoters and induces a state that favors viral replication.  
Gamma-herpesviruses Epstein-Barr virus (EBV) and Kaposi Sarcoma’s Herpes 
Virus (KSHV), fall for the most part in the first two categories. EBV nuclear antigen 2 
(EBNA2) is a universal transcriptional activator and is one of the first genes expressed 
after EBV infection. Functionally EBNA2 seems to mimic NICD very closely by 
interacting with Notch transcription factor CBF1/RBP-Jκ (Grossman et al. 1994; Henkel 
et al. 1994; Waltzer et al. 1994). The effect of EBNA2 is counter-regulated by EBNA 3B 
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and EBNA 3C, which prevent EBNA2 from binding to RBP-Jκ and underscores the 
importance of a delicate balance of gene activation through RBP-Jκ (Johannsen et al. 
1996; Robertson et al. 1995; Waltzer et al. 1996). EBNA3C can also form complexes 
with HDAC1 to inhibit transcription (Radkov et al. 1999). Another EBV protein, latency 
BamHI-A rightward transcript (BART) RPMS also interacts with Notch components to 
antagonize EBNA2. RPMS binds to the co-repressor complex associated with 
CBF1/RBP-Jκ to inhibit transcription (Zhang et al. 2001).  
 
KSHV is able to modulate Notch signaling through two viral proteins. Replication 
and transcription activator (RTA) which is the key master switch for viral lytic 
replication and latency associated nuclear antigen (LANA) which is a critical factor in the 
establishment and maintenance of latency. Both proteins interact with CBF1/RBP-Jκ to 
modulate Notch downstream gene expression (Lan et al. 2005; Lan et al. 2005; Liang et 
al. 2002). The promoters upstream of both RTA and LANA, have RBP-Jκ binding sites, 
which allows each protein to control expression of the other making the Notch pathway a 
major protagonist in the latency-reactivation switch. KSHV interacts with the Notch 
pathway in another novel way. Stability of NICD is tightly regulated by the ubiquitin-
proteasome pathway and Sel10, a ubiquitin E3 ligase enzyme, which ubiquitinates NICD 
and targets it for degradation (Gupta-Rossi et al. 2001; Oberg et al. 2001; Wu et al. 
2001). KSHV LANA directly interacts with Sel10 preventing ubiquitination and 
degradation of NICD, which constitutively activates the Notch pathway (Lan et al. 2007). 
CBF1/RBP-Jκ binding sites have also been identified in various adenoviral 
promoters (Ansieau et al. 2001). This led to the discovery that two viral gene products, 
DNA-binding protein (DBP) and E1A, interact with cellular proteins involved in the 
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Notch pathway. E1A is an oncoprotein that activates CBF1/RBP-Jκ-dependent gene 
expression by binding to CBF1/RBP-Jκ and displacing the co-repressor complex 
(Ansieau et al. 2001). E1A also interacts with two HAT complexes, which regulate Notch 
signaling (CBP/p300 and TRRAP/GCN5), by modulating their chromatin remodeling 
functions (Barbeau et al. 1994; Eckner et al. 1994; Eckner et al. 1994; Lang et al. 2003). 
SRCAP and p400 are cellular proteins that associate with CBP/p300 complexes and 
function in chromatin remodeling (Cai et al. 2003; Doyon et al. 2004; Monroy et al. 
2001). E1A binds to both proteins and antagonizes SRCAP, while it enhances p400 
function (Fuchs et al. 2001; Johnston et al. 1999). A second adenoviral protein DBP also 
interacts with SRCAP and it inhibits its activity (Xu et al. 2001; Xu et al. 2003). 
Another DNA virus that manipulates Notch signaling is SV40. Notch induction is 
regulated at the transcriptional level and requires expression of two viral proteins, large 
T-antigen and small t-antigen (Bocchetta et al. 2003). 
High-risk HPV16 oncoproteins E6 and E7 stimulates Notch1 expression in 
murine and human primary cell lines (Weijzen et al. 2003), which consequently has an 
effect on regulating HPV transcription (Lathion et al. 2003). 
HCV is the first RNA virus shown to modulate the Notch signaling pathway 
(Ghosh et al. 2000; Iwai et al.), however it is not clear whether there is an effect on the 
Notch pathway under physiological conditions during HCV infection and replication. It is 
also unclear whether the activation of Notch signaling has an effect on the life cycle of 
HCV. 
 
IV. D. Viral regulation of Notch signaling has oncogenic potential 
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Notch activation is oncogenic in many contexts, because it typically results in the 
inhibition of differentiation, enhancement of cell cycle progression and prevention of 
apoptosis. Intracellular forms of all four Notch homologues function as oncogenes and 
have transformation ability in vitro and in animal models (Bellavia et al. 2000; Callahan 
et al. 2001; Capobianco et al. 1997). To date, all of the viruses that modulate the Notch 
pathway have oncogenic properties. 
In vitro infection of B cells with EBV leads to the establishment of immortal 
lymphoblastoid cell lines. EBV immortalizing protein EBNA-2, which is necessary for 
EBV-induced transformation, activates CBF1/RBP-Jκ, thus mimicking NICD (Grossman 
et al. 1994; Henkel et al. 1994; Hsieh et al. 1997; Miller et al. 1974; Waltzer et al. 1994). 
The ability of EBNA2 to contribute to B cell immortalization is dependent upon its 
interaction with CBF1/RBP-Jκ (Yalamanchili et al. 1994). 
KSHV infection is essential for the development of Kaposi sarcoma (KS). Notch 
signaling plays a pivotal role in the KSHV life cycle. RTA activates main lytic phase 
promoters through binding to RBP-Jκ which is a major end point in the Notch signal 
transduction pathway (Liang et al. 2002). The latency protein LANA plays a central role 
in the deregulation of various cellular functions including accumulation of the 
intracellular domain of Notch in KSHV mediated tumorigenesis (Lan et al. 2005). KSHV 
also modulates Notch signaling by directly increasing the expression of two Notch 
ligands (JAG1 and DLL4) through vFLIP and vGPCR respectively in lymphatic 
endothelia (Emuss et al. 2009). This indicates that KSHV infection manipulates the 
Notch signaling pathway to induce unregulated cell proliferation and differentiation. 
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Adenovirus E1A is an oncoprotein because it promotes cell cycle progression, 
inhibition of differentiation, immortalization and transformation (Bayley et al. 1994). The 
oncogenic properties of E1A are multifactorial, however the Notch pathway activation 
through direct binding of CBF1/RBP-Jκ, and its interaction with SRCAP and p400 is 
important for oncogenesis (Ansieau et al. 2001; Fuchs et al. 2001; Johnston et al. 1999). 
E1A interactions with p400 are necessary for its transformation ability (Fuchs et al. 
2001). 
Notch activation has also been implicated as part of the SV40-mediated cell 
transformation. Large T-antigen and small t-antigen activation of Notch is required for 
growth of transformed mesothelial cells along with inhibition of the tumor suppressor 
proteins, Rb and p53 (Bocchetta et al. 2003). 
High risk HPV16 encodes two viral oncogenes, E6 and E7, which are necessary 
for the transformation of cervical epithelial cells (zur Hausen 1996). These viral proteins 
disrupt the cell cycle by degrading p53 and Rb (Dyson et al. 1989; Scheffner et al. 1990). 
However, the regulation of p53 and Rb is not sufficient for transformation. E6 and E7 
independently upregulate transcription of the Notch receptor, which is important for 
inducing transformation of human and mouse primary cells (Weijzen et al. 2003).  
HCV is thought to play an important role in the development of HCC (Banerjee et 
al.). Two viral proteins, NS3 and NS5A, which play an important role in viral replication, 
can independently transform cells in vitro (Gale et al. 1999; Park et al. 2000; Sakamuro 
et al. 1995; Tsuchihara et al. 1999). Interaction of these proteins with the Notch pathway 
suggests transformation requires regulation of Notch signaling (Ghosh et al. 2000; Iwai et 
al.). 
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FIGURES 
 
Figure 1.1: Schematic of the BHV-1 genome 
Panel A: Schematic representation of a class D herpesvirus genome. Class D genomes 
contain two unique regions (UL and US), each flanked by inverted repeats (TRL/IRL and 
TRS/IRS). BHV-1 genome is 135 kb with unique long (UL, 104 kb) and unique short (US, 
11 kb) segments, which are flanked by inverted internal repeats (IR) and terminal repeats 
(TR). 
Panel B: Schematic representation of the BHV-1 genome. L and S indicate the unique 
long and short regions, respectively. The boxes represent the inverted and terminal 
repeats. The positions of the maps units are below the schematic of the genome. Positions 
of IE transcripts and the LR transcript are presented. IE/4.2 is the IE transcript that 
encodes bICP4. IE/2.9 is the IE transcript that encodes bICP0. One IE promoter activates 
expression of IE/4.2 and IE/2.9 and this IE transcription unit is designated IEtu1. E/2.6 is 
the early transcript that activates expression of E2.6, which encodes bICP0. Exon 2 (e2) 
of bICP0 contains all of the protein coding sequences of bICP0. The origin of replication 
(ORI) separates IEtu1 from IEtu2. IEtu2 encodes a protein bICP22. Solid lines in the 
transcript position map represent exons (e1, e2, or e3). 
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Figure 1.2: Schematic representation of LR gene products 
Panel A: Partial restriction map, location of LR-RNA, organization of LR ORF, ORF E, 
and of bICP0. Reading Frame C contains an open reading frame, but lacks an initiating 
Met. The (*) denote the position of stop codons that are in frame with the respective 
ORF. 
Panel B: Expanded map of the PstI fragment that contains the LR promoter, 5’ terminus 
of the LR transcript, and the putative ORF-E transcript. The AT-rich sequences located 
near the start site of the LR-RNA are postulated to promote ORF-E transcription, and the 
arrow denotes the start sites for LR-RNA transcription (nucleotide 724). The numbers 
indicate the mapped start sites for LR transcription during latent and lytic infections. The 
white box represents the neuronal specific binding (NSB) site within the LR promoter. 
Also shown for reference is the termination site for bICP0 translation (bp 960). 
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Figure 1.3: The core Notch pathway 
Binding of the Delta ligand (green) on one cell to the Notch receptor (purple) on another 
cell results in two proteolytic cleavages of the receptor. The ADAM10 or TACE (TNFα-
converting enzyme) metallo-protease (yellow) catalyses the S2 cleavage, generating a 
substrate for S3 cleavage by the γ-secretase complex (brown). This proteolytic processing 
mediates release of the Notch intracellular domain (NICD), which enters the nucleus and 
interacts with the DNA-binding CSL protein (orange). The co-activator Mastermind 
(Mam; green) and other transcription factors are recruited to the CSL complex, whereas 
co-repressors (Co-R; blue and grey) are released (Bray 2006). 
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Figure 1.3:  
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Table 1.1: Names of core components of Notch signaling (ligand, receptor and 
transcription factor) in different species (Lai 2004) 
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GOALS OF THIS STUDY 
 
 The survival strategy of alphaherpesvirinae subfamily members relies on their 
ability to establish latency in sensory neurons innervating the site of primary infection 
followed by periodic reactivation to facilitate transmission. This aspect of the 
herpesvirus’s lifecycle is simultaneously one of the most clinically relevant and the least 
understood. Consequently, the overall goal of this study is to develop an understanding 
by which a viral protein expressed in latently infected neurons, ORF2, promotes the 
bovine herpesvirus 1 (BHV-1) latency-reactivation process. 
 
During the lytic phase of BHV-1 infection, there are at least 73 viral genes that 
are expressed leading to an efficient productive infection through interactions with both 
viral and host factors. In contrast, during the latent phase, abundant viral gene expression 
is limited to only the latency related (LR) gene. The LR gene encodes proteins and 
noncoding small RNAs, which promote efficient establishment and/or maintenance of 
latency. These LR gene products promote latency by suppressing viral gene expression, 
promoting cell survival, and interfering with immune recognition.  
 
The LR gene contains 2 major open reading frames (ORFs) ORF2 and ORF1 and 
two reading frames that lack an initiating methionine, RF-C and RF-B (Kutish et al. 
1990). Previous genetic studies provided evidence that ORF2 is necessary for the BHV-1 
latency-reactivation cycle in cattle.  ORF2 inhibits apoptosis in the absence of other viral 
genes (Shen et al. 2008) and interacts with two receptors of the Notch signaling pathway 
(Workman et al. 2011). Since these are two distinct functions of ORF2, the first 
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hypothesis of these studies is that ORF2 contains multiple domains that mediate the 
respective functions of ORF2. The goal of the studies in Chapter II was to identify 
important functional domains, which would help us understand the functions of ORF2.  
By inhibiting apoptosis and interfering with Notch signaling through ORF2, BHV-1 
could efficiently influence (Bray 2006; Ehebauer et al. 2006) neuronal maintenance, 
development, and differentiation (Berezovska et al. 1999; Cornell et al. 2005; Justice et 
al. 2002) as well as protect neurons from virus-induced apoptosis, promoting the 
establishment of latency in sensory neurons.    
 
Our previous studies provided evidence that activated Notch signaling trans-
activates certain viral promoters and productive infection, and ORF2 interferes with these 
functions. Questions still remain with respect to whether ORF2 can influence all cellular 
functions of activated Notch signaling. My second hypothesis is that ORF2 serves as a 
universal Notch pathway inhibitor because activated Notch may interfere with a latent 
infection. Therefore the goal of the studies in Chapter III was to test whether ORF2 
inhibits Notch cellular functions. This is important because in neurons, untimely 
activation of Notch signaling can inhibit neurite sprouting (Berezovska et al. 1999; 
Franklin et al. 1999; Levy et al. 2002; Sestan et al. 1999) and axon repair (El Bejjani et 
al. 2012), which can result in neuronal cell death (Coleman et al. 2010; Raff et al. 2002). 
With respect to BHV-1 infection of sensory neurons, maintaining the health of neurons 
and promoting their survival is crucial for the establishment and maintenance of life-long 
latency. 
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Our examination of the ORF2 amino acid sequence led to the identification of a 29 amino 
acid domain that resembles cellular transcription factors of the Sp family that specifically 
bind GC rich DNA sequences. The third hypothesis of these studies is that ORF2 also 
binds to DNA and that this function plays a role in the latency-reactivation cycle. 
Therefore the goal of the studies in Chapter IV was to provide evidence of ORF2-DNA 
interactions.  
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MATERIALS AND METHODS 
 
Cells and viruses 
Murine neuroblastoma cells (Neuro-2A), rabbit skin cells (RS) and human 
embryonic kidney  (Hek293) cells were grown in Earle’s modified Eagle’s medium 
(EMEM) supplemented with 5% FCS, penicillin (10 U/ml), and streptomycin (100 
μg/ml). 
A BHV-1 mutant containing the LacZ gene in place of the gC gene was obtained 
from S. Chowdury (Baton Rouge, LA) (gCblue virus) and has been previously described 
(Geiser et al. 2002; Geiser et al. 2003; Workman et al. 2010).  Stock cultures of gCblue 
were prepared in established bovine kidney cells (CRIB).  The virus grows to similar 
titers as the wild type (wt) virus and expresses the LacZ gene as a late gene. 
 
Plasmids and transient transfections 
The mammalian ORF2 construct was described previously (Shen et al. 2008).  
Briefly, sequences derived from cDNA at 1 day post infection (dpi) were cloned into 
pCMV-Tag-2B (Stratagene, La Jolla, CA) downstream of a Flag epitope using BamHI-
HindIII restriction enzymes. In pCMV-TAG-2A ORF2 is cloned as a single nucleotide 
frame shift which expresses the mRNA but not the protein (Shen et al. 2008). Sequences 
derived from ORF2 cDNA at 1day post infection (dpi) with a nuclear localization signal 
(NLS) deletion (aa 64-70) (ORF2-NLS), with PKA/PKC (ORF2-P) or all (ORF2-AP) 
putative phosphorylation sites mutated were synthesized by Integrated DNA Technology 
(IDT; Coralville, IA) and cloned into the pCMV-Tag-2B plasmid using BamHI-HindIII 
restriction enzymes. ORF2 was also synthesized as a codon-optimized protein for 
43 
 
bacterial expression. Briefly, codon-optimized ORF2 was synthesized with XhoI and 
HindIII sites introduced at the 5’ and 3’ ends of the gene, respectively.  ORF2 sequences 
were then cloned downstream of six histidine amino acid residues and an Xpress epitope 
in the vector, pRSET-A (Invitrogen, USA) at the unique XhoI and HindIII sites.A 
construct containing the Notch1 intracellular domain (ICD) was cloned into a human 
cytomegalovirus expression construct and has been previously described (Workman et al. 
2011). These constructs were gifts from U. Lendahl, Karolinska Institute, Sweden 
(Lardelli 1996). The construction and characteristics of the bICP0 early promoter-CAT 
(chloramphenicol acetyltransferase) construct (EP-172) used in this study were described 
previously (Workman et al. 2011; Workman et al. 2010).  The number in the plasmid 
name refers to the length of the bICP0 E promoter fragment cloned into the promoterless 
vector, pCAT-basic.  A plasmid containing the firefly-luciferase gene downstream of the 
HES5 promoter was a kind gift from (R. Kopan, Washington University, St Louis, MO). 
Transient transfections were performed into Neuro-2A cells using TransIT Neural 
(MIR2145; Mirus), or into Rabbit Skin cells (RS) using Lipofectamine 2000 (11668-019; 
Invitrogen) according to the manufacturer’s instructions. 
 
Generation of ORF2 mutants by EZ::TN in-frame linker insertion 
In-frame linker insertion mutants were prepared according to the manufacturer’s 
instructions (Epicentre Cat # EZ104KN).  ORF2 cDNA was released from pCMV2B-
ORF2 using BamHI-SalI endonucleases and cloned into pUC57. This plasmid was used 
as a target DNA in the reaction. The transposon reaction was set up as follows: 1μl EZ-
Tn5 10x reaction buffer, 200 ng target DNA, 1μl EZ-Tn5 <NotI/KAN-3> transposon, 6 
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μl dH2O, 1 μl transposase. The reaction mixture was incubated at 37° C for 2 hours. To 
stop the reaction, 1 μl of EZ-Tn5 10x stop solution was added and the reaction mixture 
was heated at 70°C for 10 minutes. Top 10 DH5α electrocompetent cells (Invitrogen) 
were transformed with 2 μl of the reaction mixture and a 1:10 dilution was plated unto 
plates containing 50 μg/ml kanamycin. DNA was extracted from random colonies and 
initial mapping was performed by digestion with the restriction endonucleases BamHI 
and HindIII. Certain clones were then sequenced to determine the precise transposon 
insertion. A panel of these mutants was digested with NotI to remove the kanamycin 
gene, re-ligated, then digested with BamHI and HindIII, and re-cloned into the pCMV2B 
Flag-tagged vector. The Flag-tagged mutant constructs were confirmed by sequencing. 
 
Yeast 2-hybrid analysis 
The yeast 2-hybrid analysis was performed by Hybrigenics (France) using ORF2 
as the prey.  The screen was performed using a mouse cDNA library from brain as bait. 
 
Immunofluorescence 
Neuro-2A cells cultured for 48 hours after transfection were washed twice with 
warm EMEM without serum and fixed in 4% paraformaldehyde for 10 minutes at 37° C.  
Cells were permeabilized with cold 100% ethanol at -20°C for 5 minutes. After washing 
three times with 1x PBS, slides were blocked with 3% BSA in PBS for 2 hours, then 
incubated with the mouse anti-Flag antibody (Sigma F1804) (1:250) (Flag-ORF2) or 
rabbit anti-cleaved caspase 3 (Cell Signaling 6238S) (1:250) for 2 hours at room 
temperature. The secondary antibody, goat anti-mouse/Alexa Fluor 633 
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(Invitrogen/Molecular Probes A21050) (1:100) or goat anti-rabbit/Alexa Fluor 488 
(Invitrogen/Molecular Probes A11008) (1:100) was added and cells were incubated for 1 
hour at room temperature in the dark.  DAPI (Thermo Scientific 46190) (1:1000) was 
used to stain nuclear DNA.  An Olympus IX 81 Inverted confocal laser-scanning 
microscope was used to collect images (excitation/emission at 488/520 nm and 633/660 
nm). For apoptosis assays, cells were incubated in EMEM media with 2% FCS for 12 
hours.  These cells were then incubated on ice (cold-shock) for 4 hours, and subsequently 
processed for immunofluorescence. 
 
Laddering Assay  
Cold-shock induced apoptosis of Neuro-2A cells was performed as previously 
described (Shen et al. 2008; Shen et al. 2009) with few modifications.  Briefly, 24 hours 
after transfection Neuro-2A cells in T25 flasks were incubated in fresh EMEM media 
with 2% serum for 12 hours. Cells were then cold-shocked on ice for 1 hour and allowed 
to recover at 37° C for 3 hours. Cells were subsequently collected and analysis of 
fragmented DNA was performed as described previously (Shen et al. 2008; Shen et al. 
2009). 
 
β-gal assay 
For apoptosis protection assays, Neuro-2A cells were grown in 60 mm plates and 
were co-transfected with 2 μg of pCMV-β-Gal plasmid and 2 μg of pCMV-Tag plasmid 
expressing Flag-tagged ORF2, or ORF2 mutants using TransIT Neural. Twenty-four 
hours after transfection, cells were cold-shocked on ice for 2 hours. Cells were then fixed, 
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stained and the number of β-gal+ cells counted as described previously (Workman et al. 
2010). The number of β-gal+ cells in cultures expressing the blank vector was set to 
100%.  The number of blue cells in cultures transfected with ORF2 or ORF2 mutants was 
divided by the number of β-gal+ cells in cultures transfected with the blank vector to 
calculate the fold difference. The results are an average of at least three independent 
experiments.   
 
For BHV-1 productive infection assays, the BHV-1 gCblue virus was used. 
gCblue and procedures for preparing BHV-1 genomic DNA have been previously 
described (Workman et al. 2010).  RS cells grown in 6 well plates were cotransfected 
with 0.83 μg of the gCblue viral genome, 1 μg Notch1 ICD and 1 μg ORF2 or ORF2 
mutants using Lipofectamine 2000. Twenty-four hours after transfection, cells were 
fixed, stained, and the number of β-gal+ cells counted. The number of blue cells in 
cultures transfected with a blank vector was used to calculate the fold difference in 
cultures transfected with Notch1 and ORF2 or ORF2 mutants. The results are an average 
of three independent experiments. 
 
Chloramphenicol acetyl transferase (CAT) reporter assay  
Neuro-2A cells grown in 60 mm dishes were co-transfected with the designated 
plasmids.  At 48 hours after transfection, cell lysate was prepared by three freeze/thaw 
cycles in 0.25 M Tris-HCl, (pH 7.4). Cell debris was pelleted by centrifugation, and 
protein concentration was determined by the Bradford assay. CAT activity was measured 
in the presence of 0.1 μCi (14C-chloramphenicol) (CFA754; Amersham Biosciences) and 
47 
 
0.5 mM Acetyl-CoA (A2181; Sigma). The reaction was incubated at 37
o
 C for 1 hour. All 
forms of chloramphenicol were separated by thin-layer chromatography. CAT activity in 
50 μg cell lysate was quantified using a Bio-Rad Molecular Imager FX (Molecular 
Dynamics, CA). Levels of CAT activity are expressed as fold induction relative to the 
vector control. 
 
Immunohistochemistry 
Immunohistochemistry was performed using an ABC kit (Vector Laboratories) 
according to the manufacturer’s specifications. Trigeminal ganglia (TG) were collected 
from calves that were mock infected, infected but in the latency phase (at least 60 days 
post initial infection) or infected and treated with dexamethasone at different time points 
to reactivate the virus. TG were fixed with formalin and then embedded in paraffin. Thin 
sections (4-5 µm) of the ganglia were cut and mounted unto glass slides. The slides were 
first incubated at 65° C for 20 mins, then washed twice in xylene for 10 mins each, twice 
in 100% EtOH for 5 mins, once in 90% EtOH for 5 mins, once in 70% EtOH for 5 mins, 
twice in distilled H2O for 5mins and three times in 1xTBS for 5mins each. To block any 
endogenous peroxidase activity, sections were incubated in hydrogen peroxide (0.03% in 
PBS, pH 7.4) for 20 mins at room temperature. Tissue sections were then washed three 
times in 1xTBS for 5 mins at room temperature followed by digestion with proteinase K 
(Dako, #S3020) for 20mins at 37° C. Tissue sections were then blocked with 5% normal 
serum diluted in 1xTBS containing 0.25% bovine serum albumin for 45 mins at room 
temperature in a humidified chamber. Slides were incubated in either Notch1 (Cell 
Signaling, #3268S), Notch3 (Santa Cruz Biotechnology, SC-5593) or ORF2 (Open 
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Biosystems, F7858) rabbit polyclonal antibodies at a 1:500 dilution, overnight in a 
humidified chamber at 4° C. The next day slides were washed in 1xTBS and incubated in 
biotinylated goat anti-rabbit IgG (Vector Labs, PK-6101) for 30 mins at room 
temperature in a humidified chamber. Avidin-biotinylated enzyme complex was added to 
the slides for 30 mins at room temperature. After three washes in 1xTBS slides were 
incubated with freshly prepared substrate (Vector Labs, SK-4800), rinsed with distilled 
water, and counterstained with hematoxylin for 1 min. The thin sections from mock-
infected calves were used as a negative control. 
 
Neurite formation assay 
Neuro-2A cells grown in 60mm plates were co-transfected with a CMV-promoter 
plasmid expressing the Notch1 or Notch3 intracellular domain, a pCMV-Tag plasmid 
expressing Flag-tagged ORF2, or ORF2 mutants and a pCMV-β-Gal plasmid. To induce 
neurite sprouting, 24 hours after transfection, cells were seeded into new plates at a low 
density of 2000 cells/cm
2
 and were starved in media with 0.5% serum for three days. 
Cells were then fixed, stained and a β-gal assay was performed as described above.  The 
percent of cells with neurites was calculated by dividing the number of β-gal+ cells with 
neurite length at least twice the diameter of the cell by the total number of β-gal+ cells. 
The results are an average of three independent experiments. 
 
Dual luciferase reporter assay 
Neuro-2A cells were seeded (8 x 10
5
 cells) in 60 mm dishes containing EMEM 
with 10% FCS 24 hours prior to transfection. Two hours before transfection, the media 
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was replaced with fresh EMEM containing 0.5 % FCS, to lower the basal levels of HES5 
promoter activity. Cells were co-transfected with a plasmid containing the firefly-
luciferase gene downstream of the HES5 promoter (1μg), a plasmid encoding Renilla 
luciferase under control of the herpesvirus TK promoter (50 ng) plus the indicated 
plasmids. Forty hours after transfection, cells were harvested and protein extracts were 
subjected to a dual luciferase-assay using a commercially available kit (Promega, E1910), 
according to the manufacturer’s instructions. Luminescence was measured using a 
Glomax 20/20 Luminometer (Promega E5331).  
 
DNA binding assay by affinity chromatography 
The mammalian ORF2 expression construct was transfected into Neuro-2A cells 
using TransIT-Neural.  Forty eight hours after transfection, monolayers were washed 
twice with cold phosphate-buffered saline, scraped from plates, and then lysed in cell 
lysis buffer (20 mM Tris-HCl (pH7.4), 10 mM MgCl2, 500 mM NaCl, 1 mM EDTA, 1 
mM β-mercaptoethanol, 10% glycerol and 100 µg/ml BSA). The lysate was sonicated for 
15 seconds prior to rotating at 4C for 30 min. Cell debris was centrifuged at 20,000 rpm 
for 15 minutes. The supernatant was subsequently desalted against dialysis buffer (20 
mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM β-mercaptoethanol, 10% 
glycerol and 100 µg/ml BSA) that was used for DNA chromatography. 
DNA-cellulose chromatography was performed by incubating 100 µg of ds- or ss-
DNA cellulose (Sigma, USA) with 1 mg (as indicated in the respective figure legend) of 
mammalian cell lysate containing ORF2 overnight at 4 C in binding buffer (20mM Tris-
HCl (pH 7.4), 50 mM NaCl, 1 mM β-mecaptoethanol, 1 mM EDTA, 100 µg/ml BSA, 
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10% glycerol, 1 mM Phenylmethanesulfonyl fluoride (PMSF) and 1x protease inhibitor 
(Roche, USA)). After the protein was incubated with the designated DNA cellulose 
beads, the beads were washed 5 times in binding buffer containing 100 mM NaCl and 
bound proteins were eluted with Laemmli SDS-PAGE buffer. Samples were subjected to 
electrophoresis by SDS-PAGE and analyzed by Western blot. To determine the 
preference of ORF2 for nucleic acid binding, yeast total RNA or Herring ds-DNA at 
different concentrations were added to DNA cellulose column with extract in competition 
experiment prior to washing step. DNA-free cellulose (Sigma, USA) was used as a 
negative control. 
 
Western Blot 
To separate soluble and nuclear fractions: 
Neuro-2A cells in 60 mm dishes were transfected with the designated plasmids 
and 48 hours after transfection cells were collected, washed once with 1xPBS and 
suspended in hypotonic buffer (10 mM Tris pH 7.5, 10 mM KCl, 0.5 mM EGTA, 1.5 
mM MgCl2, and 0.5% Triton X-100). Cells were vortexed, then centrifuged at 5000 x G 
for 2 minutes, and the supernatant collected.  The pellet was suspended in RIPA buffer 
(50 mM Tris-HCl, pH 8, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% sodium 
dodecyl sulfate, 1% Triton X-100), and incubated at 4° C for 30 minutes with rotation. 
Lysate was centrifuged at 14,000 rpm for 10 minutes and the supernatant was collected.  
Proteins were boiled in Laemmli sample buffer for 5 minutes and separated on a 12% 
SDS-polyacrylamide gel.  Immune-detection of ORF2 and its mutants were performed 
using a mouse anti-Flag antibody (Sigma F1804) (1:500). A polyclonal Goat anti-Actin 
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(Santa Cruz SC-1616) antibody was used to confirm that equal protein amounts were 
loaded. A Goat anti-Histone 3 (Santa Cruz SC-8654) was used as a control for detecting 
nuclear proteins in the respective cellular fractions. 
 
For Notch degradation experiments: 
 Neuro-2A cells were transfected with the designated plasmids then collected, 
washed once with 1xPBS and suspended in RIPA buffer (50 mM Tris-HCl, pH 8, 150 
mM NaCl, 0.5% sodium deoxycholate, 0.1% Sodium Dodecyl Sulfate, 1% TritonX-100, 
protease inhibitor) and incubated at 4° C for 30 mins with rotation. Lysates were cleared 
by centrifugation at 14k rpm for 10 mins. Protein concentration was measured using the 
standard Bradford assay. Equal amounts of protein were boiled in Laemmli sample buffer 
for 5 minutes and separated on a 10% SDS-polyacrylamide gel. Mouse anti-Flag 
antibody (1:500) was used to detect wt and mutant ORF2 while Notch3 was detected 
using a rabbit anti-Notch3 antibody (Santa Cruz Biotechnology, SC-5593). Goat anti-
Actin was used to confirm equal protein loading. To block protein synthesis, 40 hrs after 
transfection cells where treated with cycloheximide (CHX) (100μM) at the indicated time 
points. To block proteasome activity cells were treated with Lactacystin (15 µM) 
(Cayman Chemical, 70980) 10 hrs prior to CHX treatment. Cells were subsequently 
processed for Western Blot. 
 
For cellular fractionation experiments: 
Neuro-2A cells in 60 mm dishes were transfected with the designated plasmids 
and 48 hours after transfection cells were collected, washed once with PBS and 
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suspended in Lysis buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 1% TritonX-100) with 
protease inhibitors (Roche #11836153001). Cell lysate was subsequently incubated at 4° 
C for 30 minutes, centrifuged at 13k rpm (Beckman Avanti 30 centrifuge, F3602 rotor) 
for 10 minutes at 4
o 
C, and the supernatant collected. The pellet was suspended in Lysis 
buffer with benzonase (Sigma #E1014), incubated at 4° C for 30 minutes, and then 
centrifuged for 10 minutes at 14k rpm and the supernatant was collected. The pellet was 
suspended in RIPA buffer (50 mM Tris-HCl, pH 8, 500 mM NaCl, 0.5% sodium 
deoxycholate, 0.1% Sodium Dodecyl Sulfate, 1% TritonX-100) and incubated at 4° C for 
30 minutes with rotation. Lysate was centrifuged at 14k rpm for 10 minutes and the 
supernatant collected. The pellet or the respective samples from each fraction were boiled 
in Laemmli sample buffer for 5 minutes and all samples were separated on a 12% SDS-
polyacrylamide gel. Immunodetection of ORF2 and its mutants were performed using 
mouse anti-Flag antibody (1:500). Endogenous cdk2 was used as a nuclear control and 
was detected using a mouse anti-cdk2 (Santa Cruz SC-6248). 
 
Statistical analysis of data 
The standard Student t-test was used to identify statistical difference. A p-value < 
0.05 was considered to be significant. 
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CHAPTER II 
 
Localization of sequences in a protein encoded by the latency related gene of bovine 
herpesvirus 1 (ORF2) that inhibits apoptosis and interferes with Notch1 mediated 
trans-activation of the bICP0 promoter 
 
The studies in this chapter are included in two separate manuscripts published in the 
Journal of Virology 
 
 
Workman, A., D. Sinani, D. Pittayakhajonwut, and C. Jones (2011). "A Protein (ORF2) 
Encoded by the Latency Related Gene of Bovine Herpesvirus 1 Interacts with Notch1 
and Notch3." J Virol 85: 2536-2546. 
 
Sinani, D. and C. Jones. (2011). "Localization of sequences in a protein encoded by the 
latency related gene of bovine herpesvirus 1 (ORF2) that inhibits apoptosis and interferes 
with Notch1 mediated trans-activation of the bICP0 promoter." J Virol 85: 12124-12133. 
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ABSTRACT 
 
Bovine herpes virus 1 (BHV-1) infection induces clinical symptoms in the upper 
respiratory tract, inhibits immune responses, and can result in life-threatening secondary 
bacterial infections. Following acute infection, BHV-1 establishes latency in sensory 
neurons within trigeminal ganglia. Periodically, reactivation from latency occurs 
resulting in virus transmission. The latency-related (LR) RNA is abundantly expressed in 
latently infected sensory neurons suggesting that LR gene products regulate the latency-
reactivation cycle. A LR mutant virus with stop codons at the amino-terminus of the first 
ORF in the LR gene (ORF2) does not reactivate from latency, in part, because it induces 
higher levels of apoptosis in infected neurons. ORF2 inhibits apoptosis in transiently 
transfected cells suggesting that it plays an important role in the latency-reactivation 
cycle. ORF2 also interacts with Notch1 or Notch3, and consequently inhibits their ability 
to trans-activate the bICP0 early and glycoprotein C promoters. In this study, we 
identified ORF2 sequences that were necessary for inhibiting cold-shock induced 
apoptosis or Notch1 mediated trans-activation of the bICP0 early promoter and 
stimulation of productive infection.  Relative to ORF2 sequences necessary for inhibiting 
apoptosis, distinct domains in ORF2 were important for interfering with Notch1 mediated 
trans-activation. Five consensus protein kinase A and/or protein kinase C 
phosphorylation sites within ORF2 regulate the steady state levels of ORF2 in transfected 
cells. A nuclear localization signal in ORF2 was necessary for inhibiting Notch1 
mediated trans-activation, but not apoptosis. In summary, ORF2 has more than one 
functional domain that regulates its stability and functional properties.  
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INTRODUCTION 
 
Bovine herpesvirus 1 (BHV-1) is a significant viral pathogen of cattle (Turin et al. 
1999) that suppresses immune responses.  Infection can result in life-threatening 
pneumonia due to secondary bacterial infections (reviewed in (Jones 2009; Jones et al. 
2007; Jones et al. 2010)).  Increased susceptibility to secondary infection correlates with 
depressed cell-mediated immunity after BHV-1 infection (Carter et al. 1989; Griebel et 
al. 1990; Griebel et al. 1987; Griebel et al. 1987).  CD8
+
 T cell recognition of infected 
cells is impaired by repressing expression of major histocompatibility complex class I 
and the transporter associated with antigen presentation (Hariharan et al. 1993; Hinkley 
et al. 1998; Nataraj et al. 1997).  CD4
+
 T cell function is impaired during acute infection 
of calves because BHV-1 infects CD4
+
 T cells and induces apoptosis (Winkler et al. 
1999).  Three viral genes (UL49.5, bICP0, and gG) can inhibit specific immune 
responses in the absence of other viral genes, reviewed in (Jones et al. 2007; Jones et al. 
2001).  The ability of bICP0 to inhibit IFN dependent transcription is crucial for 
pathogenesis because BHV-1 does not grow in mice unless they lack IFN receptors 
(Abril 2004).  BHV-1, due to its immune-suppressive properties, is a significant risk 
factor for a multi-factorial disease commonly referred to as bovine respiratory disease 
complex.   
 
Like other alpha-herpesvirinae subfamily members, the primary site for BHV-1 
latency is sensory neurons within trigeminal ganglia (TG).  Lytic cycle viral gene 
expression (Schang et al. 1997) and infectious virus (Inman et al. 2002) are detected in 
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TG, but latency is subsequently established.  Increased corticosteroid levels, as a result of 
stress, can initiate BHV-1 reactivation from latency (Jones et al. 2010).  Administration 
of the synthetic corticosteroid dexamethasone to calves or rabbits latently infected with 
BHV-1 reproducibly leads to reactivation from latency, virus shedding, and a secondary 
antibody response (Inman et al. 2002; Jones 1998; Jones 2003; Jones et al. 2000; Jones et 
al. 2006; Rock et al. 1992). Induction of lytic cycle viral gene expression is consistently 
detected in TG neurons of calves latently infected with BHV-1 following dexamethasone 
treatment. 
 
The BHV-1 latency related (LR) gene expresses an abundant transcript (LR-
RNA) in latently infected sensory neurons (Rock et al. 1987; Rock et al. 1987).  The LR 
gene contains 2 major open reading frames (ORF) ORF2 and ORF1 and two reading 
frames that lack an initiating methionine, RF-C and RF-B (Kutish et al. 1990). The LR 
gene is also antisense with respect to an important viral transcriptional regulator, bICP0, 
suggesting LR-RNA reduces bICP0 levels.  Small non-coding RNAs, including two 
micro-RNAs, encoded within the LR gene inhibit bICP0 protein expression in transient 
transfection assays (Jaber et al. 2010).  A mutant BHV-1 strain with 3 stop codons at the 
N-terminus of ORF-2 (LR mutant virus) does not express detectable levels of ORF-2 or 
RF-C (Jiang et al. 2004) but expresses reduced levels of ORF1 in cultured cells during 
productive infection (Meyer et al. 2007). The LR mutant virus grows less efficiently in 
the ocular cavity or trigeminal ganglia, and does not reactivate from latency following 
dexamethasone treatment (Inman et al. 2001; Inman et al. 2002) suggesting that 
expression of LR proteins is required for the latency-reactivation cycle in cattle.  During 
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establishment of latency, the LR mutant virus induces higher levels of apoptosis in TG 
neurons of infected calves (Lovato et al. 2003), and plasmids with the same stop codon 
mutations exhibit little or no anti-apoptosis activity (Ciacci-Zanella et al. 1999; 
Henderson et al. 2004). ORF2 coding sequences, in the absence of other viral genes, 
inhibit apoptosis in transiently transfected cells (Shen et al. 2008) suggesting ORF2 is a 
dominant function encoded by the LR gene.   
 
Notch receptor family members (Notch1-4) are membrane tethered transcription 
factors that regulate numerous developmental and physiological processes (Bray 2006; 
Ehebauer et al. 2006).  For example, Notch promotes neuronal maintenance, 
development, and differentiation (Berezovska et al. 1999; Cornell et al. 2005; Justice et 
al. 2002).  Notch3 (Wang et al. 2007) and Notch1 (Naidr et al. 2003; Sade et al. 2004) 
promote cell survival by activating a protein kinase, AKT, that inhibits apoptosis.  Other 
studies have concluded that Notch family members induce apoptosis (Bray 2006; 
Ehebauer et al. 2006) suggesting Notch influences cell survival in a cell-type dependent 
fashion.  When the Notch receptor is engaged by its ligands, the Notch intracellular 
domain (NICD) is cleaved by specific proteases, and is subsequently translocated to the 
nucleus where it interacts with members of the CSL family of transcriptional repressors.  
In general, the NICD-CSL complex binds to specific DNA sequences in certain 
promoters and subsequently activates genes that regulate growth, cell survival, and 
differentiation (Bray 2006; Ehebauer et al. 2006). 
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In the current study, we provide evidence that ORF2 interacts with Notch1 and 
Notch3 proteins. Additional studies suggest that Notch family members may play a role 
in reactivation from latency. For example, the Notch1 ICD stimulates productive 
infection as well as the bICP0 immediate early and early promoters.  Secondly, Notch1 
and Notch3 trans-activated a late BHV-1 promoter, glycoprotein C (gC).  Thirdly, ORF2 
interfered with the ability of the Notch1 or Notch3 ICD to trans-activate the bICP0 E and 
gC promoters. A panel of ORF2 mutants was designed and analyzed for their ability to 
inhibit apoptosis and interfere with the trans-activation potential of Notch1.  Compared to 
domains in ORF2 that were important for anti-apoptosis, distinct domains were necessary 
for interfering with Notch1 mediated trans-activation of the bICP0 early promoter and 
productive infection.  Localization of ORF2 to the nucleus was necessary for inhibiting 
Notch1 mediated trans-activation of the bICP0 E promoter, but not inhibiting apoptosis.  
Mutating putative protein kinase A (PKA) and/or PKC phosphorylation sites stabilized 
ORF2 steady state levels, but had no obvious effect on inhibiting apoptosis or interfering 
with Notch1 mediated trans-activation of the bICP0 early promoter.  In summary, distinct 
domains within ORF2 were necessary for inhibiting apoptosis and interfering with 
Notch1 mediated trans-activation of the bICP0 early promoter. 
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RESULTS 
 
Notch1 and Notch3 interacted with ORF2 in a yeast two-hybrid screen.   
We previously found that a protein encoded by an alternatively spliced LR 
transcript (7 dpi cDNA) interacts with a cellular transcription factor, c/EBP-alpha (Meyer 
et al. 2007).  The protein encoded by the 7 dpi cDNA is a fusion between ORF2 and 
ORF1 (Devireddy et al. 2003; Devireddy et al. 1998) (Figure 2.1).  Approximately 2/3 of 
this fusion protein is derived from ORF1.  Recent studies have demonstrated that just the 
expression of ORF2 aa sequences (Figure 2.1) reduces cold-shock induced apoptosis in 
transfected mouse neuroblastoma cells (neuro-2A) (Shen et al. 2008).  The LR mutant 
virus that does not express LR proteins, including ORF2, (Jiang et al. 2004) induces 
higher levels of apoptosis in TG neurons during late stages of acute infection (Lovato et 
al. 2003) indicating that the anti-apoptosis functions of ORF2 are important for the 
latency-reactivation cycle.  Consequently, we were interested in identifying cellular 
proteins that interact with just ORF2.  To this end, a yeast two-hybrid assay was 
performed using only ORF2 sequences.  Multiple clones of Notch1 and Notch3 were 
identified in the yeast two-hybrid screen suggesting that ORF2/Notch interactions were 
stable.  Since Notch family members regulate many developmental processes 
(Berezovska et al. 1999; Cornell et al. 2005; Justice et al. 2002), we focused our studies 
on the interactions between ORF2 and Notch1 or Notch3, and whether Notch family 
members have the potential to regulate productive infection.    
 
ORF2 colocalizes with Notch1 and Notch3 and interferes with their function 
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 Additional studies were performed to verify that ORF2 interacted with Notch1 
and Notch3.  Initially, studies were performed to localize ORF2, Notch1, and Notch3.  A 
plasmid that expresses a Flag-tagged ORF2 (Shen et al. 2008) was transfected into mouse 
neuroblastoma cells (neuro-2A) to determine its sub cellular localization by confocal 
microscopy.  We have consistently detected ORF2 near the periphery of the nucleus 
(Figure 2.2.A).  As expected, the Flag-specific monoclonal antibody did not stain mock-
transfected cells (Sinani et al. 2011). Plasmids that express the ICD of Notch1 and 
Notch3 were used for these studies because they are constitutively activated and the 
respective proteins localize to the nucleus (Bray 2006; Ehebauer et al. 2006).  As 
expected, Notch1 ICD (Figure 2.2.B) and Notch3 ICD (Figure 2.2.C) were diffusely 
localized throughout the nucleus of neuro-2A cells.   
 
When the ORF2 expression plasmid was cotransfected with the Notch1 ICD, we 
consistently found that in over 97% (38 out of 39) of cells expressing both Notch1 and 
ORF2, ORF2 was diffusely localized throughout the nucleus (Figure 2.3.B), and 
appeared to co-localize with Notch1.  Conversely, the Notch3 ICD localized to the 
peripheral area within the nucleus in cells that expressed both proteins (Figure 2.3.D) in 
18/25 cells, which suggested Notch3 co-localized with ORF2.  Consistent with the results 
shown in Figure 2.2.A, ORF2 localized to peripheral areas of the nucleus in the absence 
of Notch1 ICD or Notch3 ICD (Figure 2.3.A and 2.3.B).  In summary, these results 
supported the yeast two-hybrid findings demonstrating that Notch1 and Notch3 interacted 
with ORF2. 
Workman et al. also found that Notch1, but not Notch3 enhances BHV-1 
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productive infection.  Only Notch1 activates the BHV-1 immediate-early transcription 
unit 1 (IEtu1) and bICP0 early promoters: whereas Notch1 and Notch3 both trans-
activated the late BHV-1 glycoprotein C (gC) promoter.  ORF2 interferes with the ability 
of Notch1 to trans-activate the bICP0 early promoter and Notch1 or Notch3 mediated 
activation of the gC promoter (Workman et al. 2011) suggesting this function is 
important for establishing and/or maintaining latency. 
 
Construction of plasmids that express ORF2 mutant proteins 
ORF2 is a 181 amino acid protein (Figure 2.4.A and B) that is expressed in a 
subset of trigeminal ganglionic sensory neurons of latently infected calves (Hossain et al. 
1995; Jiang et al. 1998).  ORF2 has anti-apoptosis activity (Shen et al. 2008) and ORF2 
interacts with Notch1 and Notch3, which results in interfering with trans-activation of 
certain viral promoters (Workman et al. 2011).  Furthermore, an alternatively spliced LR-
transcript encodes a protein containing part of ORF2 fused with ORF1, and this protein 
interacts with C/EBP-alpha (Meyer et al. 2007; Workman et al. 2011). Since ORF2 
appears to have at least two distinct functions, we hypothesized that ORF2 has more than 
one functional domain.  A BLAST analysis of ORF2 did not reveal extensive similarity 
to known proteins, and thus did not provide insight into the mechanism by which ORF2 
inhibits apoptosis or regulates transcription. To identify functional domains within ORF2, 
a panel of transposon insertion mutants was constructed in which a 57-nucleotide 
sequence was randomly inserted into the template (see Figure 2.4.B for the insertion site 
of the respective mutants). The EZ::TN linker insertion method was previously used to 
successfully generate a panel of bICP0 mutants, which is also a high GC template (Zhang 
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et al. 2005).  This approach was used because ORF2 deletion mutants that were 
constructed did not encode a stable protein, whereas the transposon mutagenesis yielded 
a panel of mutants that spanned the protein.   
 
Each transposon mutant was cloned into a Flag-tagged CMV expression plasmid 
and transfected into Neuro-2A cells. At 48 hours after transfection, proteins were 
extracted using hypotonic buffer.  Nuclei as well as other debris were separated from the 
supernatant by centrifugation, and the pellet was then solubilized with RIPA buffer.  
Western blots were performed using an anti-Flag antibody to assess expression levels of 
the respective transposon mutants.  ORF2 is predicted to encode a 19 kDa protein and a 
prominent band migrating near the predicted molecular weight was detected (Figure 
2.4.C; closed circle).  The ORF2 transposon mutants migrated at an approximate 
molecular weight of 23 kDa (closed triangle) because of the additional 19 amino acids in 
the transposon insertion (Figure 2.4.C). The higher molecular weight bands detected by 
the Flag antibody (denoted by the bracket) were specific for cells transfected with wt 
ORF2 or the respective transposon mutants of ORF2, and were not detected in cells 
transfected with the empty vector.  We suggest these higher molecular weight bands were 
post-translationally modified ORF2.  β-actin levels in the respective lanes were similar 
indicating equivalent amounts of protein were loaded.  Except for ORF2-95, the other 
transposon mutants expressed similar levels of protein as wt ORF2 (Figure 2.4.C).  In the 
pellet of cells transfected with ORF2, ORF2-240, ORF2-271, ORF2-333, ORF2-469, or 
ORF2-529, an ORF2 specific band was readily detected suggesting that ORF2 and 
certain mutants were tightly associated with cellular structures.  This results was 
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consistent with a previous study demonstrating that ORF2 is localized to distinct regions 
of the nucleus (Workman et al. 2011).  Low levels of histone 3 were detected in the 
supernatant indicating this fraction contained low levels of nuclear proteins as well as 
cytoplasmic proteins.  High levels of histone 3 were present in the pellet, as expected, 
confirming that tightly bound nuclear proteins were associated with the pellet.  Other 
extraction buffers yielded variable results (data not shown) further suggesting that ORF2 
was associated with cellular structures and extraction of ORF2 was dependent on the 
buffers used.  
 
Within ORF2, there are 15 potential phosphorylation sites (grey shaded amino 
acids; Figure 2.4.A), which may explain why ORF2-specific bands migrating between 
26-30 kDa were detected in transfected cells.  Among the 15 putative phosphorylation 
sites, five consensus protein kinase A (PKA) and/or PKC phosphorylation sites were 
present (grey shaded amino acids with white lettering; Figure 2.4.A).  A mutant (ORF2-
AP) containing all 15 putative phosphorylation sites and a mutant with the 5 PKA/PKC 
phosphorylation sites (ORF2-P) was synthesized in which the serine, threonine, or 
tyrosine residues in the wt sequence were replaced with alanine.  Mutating the putative 
phosphorylation sites to alanine increased the stability of ORF2-AP (Figure 2.4.C, lane 
AP) or ORF2-P (lane P) relative to wt ORF2.  Furthermore, higher levels of the ORF2 
phosphorylation mutants were detected in the pellet.  The phosphorylation mutants also 
had little or no higher molecular weight bands adding support to the prediction that ORF2 
may be phosphorylated by a cellular protein kinase.   
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A consensus nuclear localization signal (NLS) (aRRcRRc) is located between 
amino acids 64-70 of ORF2 (Devireddy et al. 2003) (Figure 2.4.A; underlined amino 
acids and 2.4.B).  To test whether this NLS was required for nuclear localization, a 
mutant (ORF2-∆NLS) containing a deletion of aa 64-70 was synthesized, cloned into the 
pCMV-FLAG vector, and transfected in Neuro-2A cells. The ORF2-∆NLS protein levels 
were similar to wt ORF2, but ORF2-∆NLS migrated primarily as a 29 kDa protein 
(Figure 2.4.D).  Unlike wt ORF2, ORF2-∆NLS was not detected in the nuclear pellet 
suggesting this protein was not present in the nucleus.    
 
Subcellular localization of ORF2 mutants 
ORF2 localized to the nuclear periphery in transfected Neuro-2Acells (Figure 
2.5), which was consistent with a previous study (Workman et al. 2011).  The ORF2-95 
mutant (Figure 2.5), which was expressed at lower levels in transfected cells (Figure 
2.4.C), was more diffusely localized throughout the nucleus relative to cells expressing 
the wt ORF2.  The other transposon mutants had a similar localization as wt ORF-2 (data 
not shown), which was somewhat surprising because certain transposon mutants 
appeared to be tightly associated with structures in the nucleus (Figure 2.4.C).   
 
The ORF2-∆NLS mutant was localized to the peripheral area of the cytoplasm 
confirming the results in Figure 2.4.D, which indicated that deletion of ORF2 amino 
acids 64-70 disrupted nuclear localization.  The phosphorylation mutants, ORF2-AP or 
ORF2-P, appeared to have similar nuclear localization as wt ORF2 even though they 
were more difficult to extract from transfected cells.  During productive infection, ORF2 
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is diffusely localized to the nucleus and cytoplasm {(Meyer et al. 2007) and data not 
shown} suggesting that a viral encoded or induced factor regulates ORF2 localization.  In 
summary, we have constructed and characterized a panel of ORF2 mutants that can be 
used to analyze the known functions of ORF2. 
 
Analysis of anti-apoptosis activity of ORF2 mutants 
Transient transfection assays were performed to compare the anti-apoptosis 
functions of ORF2 to the respective mutants described in Figure 2.4.  For these studies, 
plasmids expressing the respective ORF2 mutants were transfected into Neuro-2A cells 
and cold-shock induced apoptosis was performed as previously described (Carpenter et 
al. 2007; Shen et al. 2008; Shen et al. 2009).  At 24 hours after transfection, cells were 
starved in 2% fetal calf serum for 12 hours, cultures were incubated on ice for 1 hour, and 
then returned to 37° C for 3 hours. DNA was then extracted and analyzed by agarose 
electrophoresis.  Neuro-2A cells or Neuro-2A cells placed on ice for 1 hour contain no 
detectable DNA laddering (Shen et al. 2008; Shen et al. 2009).  However, extensive 
DNA laddering, indicative of apoptosis, occurs when Neuro-2A cells are returned to 37
o 
C for 3 or 6 hours (Shen et al. 2008; Shen et al. 2009).  ORF2 and Bcl-2, an inhibitor of 
the intrinsic apoptotic pathway (Yang et al. 1997), inhibited cold shock-induced 
apoptosis with similar efficiency (Figures 2.6.A and B).  ORF2-310 and ORF2-469 
mutants were unable to inhibit cold-shock induced apoptosis when compared to wt ORF2 
(Figure 2.4.A and B).  The anti-apoptosis activity of wt ORF2 was significantly different 
than ORF2-310 or ORF2-469 (p<0.008 or 0.01 respectively). The ability of the other 
transposon insertion mutants to inhibit cold-shock induced apoptosis in Neuro-2A cells 
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was not significantly different than wt ORF2 (p>0.05).  Although the ORF2-95 mutant 
was expressed at lower levels relative to wt ORF2, it still retained anti-apoptosis activity 
suggesting that low levels of ORF2 were sufficient for inhibiting apoptosis.   
 
Neuro-2A cells expressing ORF2-∆NLS (Figure 2.6.C) were protected against 
cold-shock induced apoptosis with similar efficiency as wt ORF2, which was surprising 
because ORF2-∆NLS was localized to the cytoplasm.  Both phosphorylation mutants 
(ORF2-P or ORF2-AP) inhibited cold shock-induced apoptosis relative to the control 
(Figure 2.6.C, p<0.05).  
 
To confirm the results in Figure 2.6, we used a β-Gal co-transfection assay (Hsu 
et al. 1995; Kumar et al. 1994) that has been modified to measure the effects of various 
genes on apoptosis (Ciacci-Zanella et al. 1999; Henderson et al. 2002; Inman et al. 2001; 
Jin et al. 2003; Perng et al. 2000).  When a known apoptosis stimulator is used, the 
number of surviving cells can be accurately measured using the β-Gal co-transfection 
assay.  For these studies, apoptosis was induced using cold shock treatment of Neuro-2A 
cell.  Neuro-2A cells transfected with a plasmid that expresses wt ORF2 exhibited at least 
a 3 fold increase in cell survival after cold shock induced apoptosis, as judged by an 
increase in the number of β-Gal+ cells (Figure 2.7). As expected, plasmids expressing 
ORF2-310 and ORF2-469 did not enhance survival.  Consistent with the studies 
performed in Figure 2.6, the other ORF2 transposon insertion mutants, ORF2-∆NLS, and 
the two phosphorylation mutants (ORF2-AP and ORF2-P) inhibited apoptosis with 
similar efficiency as wt ORF2.  Cell survival was consistently higher in cells expressing 
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ORF2-∆NLS, or the phosphorylation mutants (ORF2-AP and ORF2-P) compared to wt 
ORF2: however the difference was not statistically different (Figure 2.7). 
 
Confocal microscopy was performed to confirm that cells expressing ORF2-310 
or ORF2-469 do not protect cells against apoptosis.  For these studies, we tested whether 
cleaved caspase 3 was present in cells expressing either wt ORF2 or the ORF2-310 and 
ORF2-469 mutants. Cleavage of caspase 3 is considered to be the “point of no return” 
during intrinsic and extrinsic induced pathways of apoptosis, and thus is an established 
marker for apoptosis induction (Granville et al. 1998; Nicholson et al. 1997; Schmitz et 
al. 2000).  Neuro-2A cells transfected with the respective plasmids were cold-shocked, 
incubated at 37
o
 C, processed for immunofluorescence, and then visualized with a 
confocal microscope.  Cleaved caspase 3 was not detected in ORF2 positive cells.  
However, cleaved caspase 3 was readily detected in cells not expressing ORF2, which 
was expected because cells that were not transfected would undergo cold shock induced 
apoptosis.  In contrast, cells expressing ORF2-310 or ORF2-469 were consistently 
positive for cleaved caspase 3 confirming these mutants do not efficiently inhibit 
apoptosis (Figure 2.8).   
 
Identification of ORF2 mutants that interfere with trans-activation of the bICP0 E-
promoter by Notch1 
As discussed above, ORF2 interacts with the cellular transcription factor Notch1, 
a component of the Notch signaling pathway that controls differentiation and 
development of all tissues (Workman et al. 2011).  Notch1 trans-activates the bICP0 
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early promoter and ORF2 reduces the trans-activation potential of Notch1.  
 
To identify domains in ORF2 that interfered with Notch1 mediated trans-
activation of the bICP0 early promoter, transient transfection assays were performed in 
Neuro-2A cells.  Notch1 over-expression activated the bICP0 early promoter 
approximately 12 fold, and ORF2 reduced Notch1 mediated trans-activation to 3 fold 
(Figure 2.9) and (Workman et al. 2011).  Four transposon mutants, ORF2-95, ORF2-134, 
ORF2-240 and ORF2-271, did not significantly reduce the ability of Notch1 to stimulate 
bICP0 early promoter activity when compared to wt ORF2 (p<0.05).  With respect to 
ORF2-95, we cannot distinguish whether this was due to lower protein expression levels 
or if an essential inhibitory domain was disrupted.  The remainder of the transposon 
mutants inhibited trans-activation of the bICP0 early promoter by Notch1 with similar 
efficiency as wt ORF2.  The phosphorylation mutants, ORF2-P and ORF2-AP, but not 
ORF2-∆NLS, also inhibited Notch1 mediated trans-activation of the bICP0 early 
promoter with similar efficiency as wt ORF2 (p>0.05).   
 
Identification of ORF2 mutants that interfere with productive infection induced by 
Notch1 
Additional studies were performed to identify ORF2 mutants that interfere with 
the ability of Notch1 to stimulate productive infection.  We hypothesized there may be 
differences in these results compared to the ability of ORF2 to interfere with the ability of 
Notch1 to trans-activate the bICP0 early promoter.  The rationale for this prediction is 
summarized below.  Eleven known consensus binding sites for CSL (RBP-Jκ) exist 
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(Persson 2010).  The Notch ICD interacts with members of the CSL family of 
transcriptional repressors (Bray 2006; Ehebauer et al. 2006).  The BHV-1 genome 
contains 82 potential binding sites for CSL, of which 23 are located in non-coding 
regions.  Thus, certain ORF2 mutants may interfere with the ability of Notch1 to trans-
activate the bICP0 promoter, but may not interfere with productive infection. 
  
To determine whether ORF2 interfered with the ability of Notch1 to stimulate 
BHV-1 productive infection, rabbit skin (RS) cells were co-transfected with a plasmid 
expressing the Notch1 ICD or the Notch1 ICD and ORF2 plus the BHV-1 gCBlue virus 
genome, and the efficiency of productive infection measured.  The gCblue virus contains 
the LacZ gene downstream of the gC promoter, which allows for measuring the 
efficiency of productive infection by counting β-Gal+ (beta-galactosidase positive) cells.  
The number of β-Gal+ cells directly correlates with plaque formation (Geiser et al. 2002; 
Geiser et al. 2003; Meyer et al. 2007; Workman et al. 2010; Workman et al. 2009).  RS 
cells were used for these studies because they are permissive for BHV-1 and can be 
readily transfected.  The Notch1 ICD expression plasmid consistently stimulated 
productive infection approximately four fold (Figure 2.10): however ORF2 reduced the 
number of β-Gal+ cells to background levels. The effects of the respective ORF2 mutants 
on Notch1 mediated activation of productive infection were then analyzed.  Five 
transposon mutants (ORF2-95, ORF2-134, ORF2-240, ORF2-271, ORF2-310) and the 
ORF2-∆NLS mutant were unable to significantly interfere with the ability of Notch1 to 
stimulate productive infection (p<0.05).  Interestingly, ORF2-310 did not interfere with 
Notch1 mediated trans-activation of the bICP0 early promoter suggesting that the ability 
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of Notch1 to stimulate productive infection was not entirely dependent on interfering 
with bICP0 early promoter activity.  ORF2-P and ORF-2AP, but not ORF2-∆NLS, 
reduced productive infection as efficiently as wt ORF2.  ORF2-333, ORF2-469, ORF2-
529, in general, had an intermediate effect on the ability of Notch1 to stimulate 
productive infection, which was not significantly different than wt ORF2 (p>0.05).  In 
general, the results in Figures 2.9 and 2.10 suggested that the amino-terminal sequences 
in ORF2 were important for inhibiting Notch1 mediated trans-activation of the bICP0 
early promoter activity and productive infection.   
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DISCUSSION 
 
LR protein expression is necessary for dexamethasone induced reactivation from 
latency in cattle (Inman et al. 2002), in part, because a LR mutant virus containing stop 
codons at the N-terminus of ORF2 induces higher levels of apoptosis in sensory neurons 
during the establishment of latency (Lovato et al. 2003).  In contrast to BHV-1, other 
alpha-herpesvirinae subfamily members (HSV-1 and HSV-2 for example) abundantly 
express several small non-coding RNAs that are proposed to mediate the latency-
reactivation cycle in small animal models (Jones 1998; Jones 2003; Perng et al. 2010).  
BHV-1 encoded ORF2 (Ciacci-Zanella et al. 1999; Shen et al. 2008) and HSV-1 LAT 
(Ahmed et al. 2002; Branco et al. 2005; Hamza et al. 2007; Inman et al. 2001; Perng et 
al. 2000) inhibit apoptosis, which promotes the survival of infected sensory neurons. The 
reduced reactivation phenotype of a HSV-1 LAT null mutant is restored to wild type 
levels when an anti-apoptosis gene is inserted in the LAT locus and is expressed during 
latency (Jin et al. 2008; Jin et al. 2005; Mott et al. 2003; Perng et al. 2002) underscoring 
the importance of enhancing survival of infected neurons.  In addition to inhibiting 
apoptosis, ORF2 interacts with at least three cellular transcription factors, C/EBP-alpha, 
Notch1, and Notch3 (Meyer et al. 2007; Workman et al. 2011), suggesting ORF2 
regulates viral and/or cellular transcription.  Thus, identifying domains in ORF2 that are 
important for inhibiting apoptosis relative to its other known functions may provide 
insight into how ORF2 regulates the latency-reactivation cycle.   
 
A previous study identified a NLS in ORF2 that matches the NLS in the cellular 
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transcription factor Sp1 (Devireddy et al. 2003).  Deletion of the NLS (ORF2-∆NLS) 
prevented localization of this mutant to the nucleus. However, the ORF2-∆NLS mutant 
protein was localized at or near the plasma membrane of transfected cells suggesting 
ORF2 can interact with membrane components.  Surprisingly, ORF2-∆NLS inhibited 
cold shock induced apoptosis with similar efficiency as ORF2 suggesting nuclear 
localization of ORF2 was not required for its anti-apoptosis functions or low levels of the 
ORF2-∆NLS protein were present in the nucleus.  Mutating all of the putative 
phosphorylation sites within ORF2 or just the consensus PKA/PKC phosphorylation sites 
led to increased levels of ORF2 in neuro-2A cells but had no effect on inhibiting 
apoptosis or Notch1 functions.  At this point, it is not clear whether phosphorylation 
regulates an unknown function of ORF2 or if it simply destabilizes ORF2.  
Phosphorylation renders many proteins susceptible to degradation, reviewed in 
(Hochstrasser 1996); including the p53 tumor suppressor protein (Zhang et al. 2001) and 
proteins that regulate cell cycle checkpoints (Hartwell et al. 1989).  The presence of PKA 
phosphorylation sites in ORF2 may have biological significance because cAMP, which 
activates PKA (Das et al. 2007), stimulates HSV-1 reactivation from latency (Leib et al. 
1991; Smith et al. 1992).  
 
 ORF2-310 and ORF2-469 were unable to inhibit cold shock induced apoptosis, 
but these mutants inhibited Notch1 mediated trans-activation of productive infection.  
These results suggested that ORF2 contains two non-overlapping functional domains and 
the amino terminus of ORF2 was important for inhibiting Notch1 mediated trans-
activation of productive infection.  For Notch family members to activate transcription in 
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the canonical Notch signaling pathway, the Notch intracellular domain must interact with 
a CSL family member that specifically binds DNA, reviewed in (Bray 2006; Ehebauer et 
al. 2006).  At least two non-canonical Notch signaling pathways exist (Sanalkumar et al. 
2010), suggesting ORF2 interferes with one or more of these pathways. ORF2-Notch 
interactions may also maintain “neuronal health” during life-long latency because 
activation of Notch signaling interferes with neurite formation (Franklin et al. 1999; Levy 
et al. 2002), which is crucial for normal neuronal functions. Conversely, ORF2 may 
capture Notch1 and Notch3 to regulate steps that are necessary for establishing or 
maintaining life-long latency in cattle.  Since Notch1 and Notch3 RNA levels are 
increased in trigeminal ganglia after dexamethasone treatment, a known stimulus for 
reactivation from latency (Workman et al. 2011), there may be more than one reason to 
overcome the deleterious effects of Notch on latently infected neurons.  Further studies 
designed to understand the effects of ORF2 on Notch signaling pathways are currently 
being pursued.   
 
In summary, we predict that ORF2 promotes survival of infected neurons by at 
least two distinct mechanisms: 1) inhibits apoptosis (Meyer et al. 2007; Shen et al. 2008; 
Workman et al. 2011) and 2) interferes with viral transcription by sequestering cellular 
transcription factors such as Notch1, Notch3 (Workman et al. 2011), or C/EBP-alpha 
(Meyer et al. 2007). C/EBP-alpha is induced during dexamethasone induced reactivation 
from latency (Meyer et al. 2007) and cooperates with bTIF, the HSV-1 VP16 homologue, 
to trans-activate the immediate early transcription unit 1 promoter (Meyer et al. 2008).  
The ability of ORF2 or an ORF2 fusion protein to interact with cellular transcription 
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factors that stimulate productive infection is believed to promote the establishment and/or 
maintenance of latency.  It is unlikely that ORF2 plays a direct role in reactivation from 
latency because LR promoter activity (Jones et al. 1990) and LR-RNA levels (Rock et al. 
1992) are reduced dramatically during dexamethasone induced reactivation from latency. 
ORF2 may not be the only important product encoded by the LR gene because other 
proteins are encoded by the LR gene (Inman et al. 2004; Meyer et al. 2007) and two 
micro-RNAs encoded by the LR gene reduce bICP0 protein levels (Jaber et al. 2010).  
The mechanism by which the additional LR gene factors support ORF2 during life-long 
latency is being examined. 
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FIGURES 
 
Figure 2.1:  Schematic of protein coding regions within the LR genes and ORF2 
isoforms encoded by alternatively spliced LR transcripts 
ORF-1 and ORF-2 are the open reading frames present in the LR gene (Kutish et al. 
1990).  Reading Frame B and C (RF-B and RF-C) each contain an open reading frame 
that lacks an initiating methionine.  The numbers in parenthesis are the approximate size 
of ORFs (Kd) that are located in LR gene sequences.  The ORF2 isoforms encoded by 
alternatively spliced LR transcripts detected in TG at 1 dpi and latency, 7 dpi, and 15 dpi, 
(Devireddy et al. 2003) are shown as a comparison to ORF2 present in the LR gene.  
Although the LR-RNA is differentially spliced at 1 day after infection in TG of cattle, 
both transcripts encode an intact ORF2.  The (*) denotes the position of stop codons that 
are in frame with the respective ORF. 
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Figure 2.2:  Localization of ORF2 and Notch family members in neuro-2A cells 
Neuro-2A cells were transfected with 4μg of plasmids expressing Flag-tagged ORF2 
(Panel A), Notch1 ICD (Panel B), or Notch3 ICD (Panel C).  Cultures were prepared for 
confocal microscopy at 48 hours after transfection as described in the materials and 
methods. Cells were stained with anti-Flag antibody (red), anti-Notch1 or Notch3 
antibody (green) or DAPI to visualize ORF2, Notch1, Notch3 and the nucleus 
respectively.  DIC (differential interference contrast) was used to show the unstained 
cells.  The images are representative of more than 5 experiments. 
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Figure 2.3:  Co-localization of ORF2 with Notch1 and Notch3  
Panels A and C. Neuro-2A cells were transfected with 4μg of the plasmid expressing N-
terminally Flag-tagged ORF2, and then prepared for confocal microscopy as described in 
Materials and Methods.  Notch1 and Notch3 antibodies (green) and DAPI (blue) were 
used to stain cells.  
Panels B and D.  Neuro-2A cells were cotransfected with 4μg of plasmids expressing N-
terminally Flag-tagged ORF2 and Notch1 or Notch3 ICD.  Empty pCMV-Tag-2B was 
used to equalize DNA amounts.  At 48 hours after transfection, cells were prepared for 
confocal microscopy.  Cells were stained with anti-Flag antibody (red), anti-Notch1 or 
Notch3 antibody (green) and DAPI (blue) to visualize ORF2, Notch1, Notch3 and the 
nucleus respectively.  The images are representative of at least three independent 
experiments. 
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Figure 2.4:  Generation of BHV-1 ORF2 mutants  
Panel A: Amino acid sequence of ORF2. NLS (underlined), 15 putative phosphorylation 
sites (grey shaded amino acids) and 5 consensus protein kinase A (PKA) and/or PKC 
phosphorylation sites (grey shaded amino acids that have white lettering) are shown.  The 
plus signs denote every 10
th
 amino acid in ORF2. 
Panel B: ORF2 coding sequences (BamHI-SalI) were cloned into the pUC57 vector and 
transposon linker insertion reactions performed as described in the materials and 
methods. Initial mapping was performed by restriction digestion and the precise location 
of the transposon insertion was confirmed by sequencing.  Vertical lines with the 
respective numbers indicate the nucleotide position of the respective transposon insertion. 
The relative position of the consensus nuclear localization signal (NLS) is denoted by the 
white rectangle.  
Panel C:  The transposon mutants and the two phosphorylation mutants were cloned into 
the pCMV-Tag-2B vector and transfected into Neuro-2A cells.  At 48 hours after 
transfection, cells were collected and lysed using hypotonic buffer as described in the 
materials and methods. After centrifugation, the supernatant was removed.  The pellet 
was suspended in RIPA buffer, the solubilized proteins were collected after centrifuging 
the residual pellet, and this fraction designated the pellet.  Detection of flag-tagged ORF2 
mutants was performed using an Anti-Flag antibody.  A β-actin antibody was used to 
confirm that equal amounts of protein were loaded in each lane.  A histone 3 antibody 
was used to identify nuclear proteins in the supernatant or pellet fraction.  ORF2 is 
predicted to migrate as a 19 kDa protein and the black circle denotes the position of this 
protein.  The arrow denotes the higher molecular weight ORF2 specific bands that 
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migrated at approximately 30 kDa, which were detected in certain samples.  The 
transposon mutants are predicted to migrate as a 22 kDa protein and are denoted by a 
closed triangle.  The * denotes the position of the ORF2-specific bands that migrated 
slower than expected.  For each lane, 100 µg protein was loaded. 
Panel D: Neuro-2A cells were transfected with the designated plasmids and the 
respective samples collected at 48 hours after transfection as described above. These 
results are representative of more than 3 independent experiments. 
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Figure 2.4: 
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Figure 2.5:  Localization of ORF2 mutants in neuro-2A cells 
Neuro-2A cells were transfected with 4μg of the designated plasmids that express a Flag-
tagged ORF2 or ORF2 mutants.  Cultures were prepared for confocal microscopy at 48 
hours after transfection as described in the materials and methods. ORF2+ cells were 
stained with the anti-Flag antibody (red), or DAPI was used to visualize ORF2 the 
nucleus (blue).  DIC (differential interference contrast) was used to show the unstained 
cells. The images are representative of more than 3 experiments. 
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Figure 2.6:  Inhibition of cold shock-induced DNA laddering by ORF2 mutants 
Panel A: Neuro-2A cells were transfected with 4μg of the plasmid expressing N-
terminally Flag-tagged ORF2 or the designated ORF2 transposon mutants. Cells were 
cold-shocked at 4°C for 1 hour and allowed to recover at 37° C for 3 hours. Neuro-2A 
cells transfected with the empty vector were used as a negative control, while Bcl-2 or 
ORF2 expressing cells were used as positive controls.  The agarose gel images are 
representative of 5 independent experiments.  
Panel B: The relative amounts of fragmented DNA in each lane in Panel A were 
quantified using a Bio-Rad molecular imager FX.  The average of 5 independent 
experiments is shown with the respective standard deviation.  
Panel C:  Neuro-2A cells transfected with the empty vector, ORF2, ORF2-∆NLS, ORF2-
P or ORF2-AP were cold shocked as in Panel A and fragmented DNA quantified as 
described in Panel B.  An asterisk denotes significant differences (p<0.05) from the 
control samples (empty vector) as determined by the Student T-test. 
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Figure 2.7:  Survival of Neuro-2A cells after transfection with ORF2 mutants  
Neuro-2A cells were co-transfected with 2 μg of the pCMV-β-Gal plasmid and 2 μg of 
the designated ORF2 expression plasmids.  Cells were cold-shocked for 2 hours and the 
β-Gal assay was performed as described in the materials and methods. The number of β-
gal+ cells in cultures expressing the blank vector was set to 100%.  The number of blue 
cells in cultures transfected with the blank vector to calculate the fold difference divided 
the number of blue cells in cultures transfected with ORF2 or ORF2 mutants.  The results 
are an average of three independent experiments.  An asterisk denotes significant 
differences (p<0.05) from the control samples (empty vector) as determined by the 
Student T-test. 
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Figure 2.8: Induction of caspase 3 cleavage by ORF2 transposon mutants 
Neuro-2A cells were transfected for 24 hours, incubated in EMEM media with 2% FCS 
for 12 hours, and then cold-shock induced apoptosis performed as described in the 
materials and methods. Cells were then processed for immunofluorescence as described 
in the materials and methods. Mouse anti-Flag antibody (Red) was used to detect Flag-
tagged ORF2 and the designated transposon mutants. Rabbit anti-cleaved caspase 3 
antibody (Green) was used to detect activated cleaved caspase 3. DAPI (Blue) was used 
to stain the nucleus. 
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Figure 2.8: 
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Figure 2.9:  Identification of ORF2 sequences that interfere with Notch1 mediated 
trans-activation of the bICP0 early promoter 
Neuro-2A cells were co-transfected with the bICP0 E promoter construct (EP-172), a 
CMV-promoter plasmid expressing the Notch1 intracellular domain and the designated 
ORF2 expressing constructs. At 48 hours post transfection, cells were collected and 
processed for CAT activity as described in the materials and methods.  CAT activity of 
cells transfected with the control CAT vector was set to one.  All other values are 
expressed as fold activation with respect to the control.  These studies are the average of 
at least three independent experiments.  An asterisk denotes significant differences 
(p<0.05) from the control samples (empty vector) as determined by the Student T-test. 
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Figure 2.10:  Identification of ORF2 sequences that interfere with Notch1 mediated 
trans-activation of productive infection 
Neuro-2A cells were co-transfected with the gCblue virus, a CMV-promoter plasmid 
expressing the intracellular domain of Notch1 and the designated ORF2 constructs. At 48 
hours after transfection, cells were fixed and a β-Gal assay performed as described in the 
materials and methods. The number of β-gal+ cells in cultures expressing the empty 
vector was set to 1.  The number of blue cells in cultures transfected with the empty 
vector to calculate the fold difference divided the number of blue cells in cultures 
transfected with Notch1 or co-transfected with Notch1 and ORF2 or ORF2 mutants.  The 
results are an average of at least three independent experiments.  An asterisk denotes 
significant differences (p<0.05) from the control samples (empty vector) as determined 
by the Student T-test. 
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CHAPTER III 
 
A protein encoded by the latency related gene of bovine herpesvirus 1 (ORF2) 
promotes neurite sprouting in the presence of Notch1 or Notch3 
 
 
 
The studies in this chapter are included in a manuscript in press in the Journal of 
Virology 
 
 
Sinani, D. and C. Jones. (In Press). "A protein encoded by the latency related gene of 
bovine herpesvirus 1 (ORF2) promotes neurite sprouting in the presence of Notch1 or 
Notch3." J Virol (In Press). 
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ABSTRACT 
 
Bovine herpes virus 1 (BHV-1) infection induces clinical symptoms in the upper 
respiratory tract, inhibits immune responses, and can lead to life-threatening secondary 
bacterial infections.  Following acute infection, BHV-1 establishes latency in sensory 
neurons within trigeminal ganglia, but stress can induce reactivation from latency.  The 
latency-related (LR) RNA is the only viral transcript abundantly expressed in latently 
infected sensory neurons.  A LR mutant virus with stop codons at the amino-terminus of 
the first ORF in the LR gene (ORF2) does not reactivate from latency, in part, because it 
induces higher levels of apoptosis in infected neurons.  ORF2 inhibits apoptosis in 
transiently transfected cells suggesting it plays a crucial role in the latency-reactivation 
cycle.  ORF2 also interacts with Notch1 or Notch3, and inhibits their ability to trans-
activate certain viral promoters.  Notch3 RNA and protein levels are increased during 
reactivation from latency suggesting Notch promotes reactivation.  Activated Notch 
signaling interferes with neuronal differentiation, in part, because neurite and axon 
generation is blocked.  In this study, we demonstrated that ORF2 is able to restore neurite 
formation in mouse neuroblastoma cells over-expressing Notch1 or Notch3.  ORF2 also 
interfered with Notch mediated trans-activation of a promoter that regulates expression of 
Hairy Enhancer of Split 5, which is a Notch target and required for inhibiting neurite 
formation.  Additional studies provided evidence that ORF2 promotes degradation of 
Notch3 in a proteasome dependent manner.  In summary, these studies suggest that ORF2 
promotes a mature neuronal phenotype, which enhances survival of infected neurons and 
consequently increases the pool of latently infected neurons. 
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INTRODUCTION 
 
Bovine herpesvirus 1 (BHV-1) is a significant viral pathogen of cattle (Turin et al. 
1999) that suppresses immune responses.  BHV-1, due to its immune-suppressive 
properties, is a significant risk factor for a multi-factorial disease commonly referred to as 
bovine respiratory disease complex {reviewed in (Jones 2009; Jones et al. 2007; Jones et 
al. 2010)}.  Like other alpha-herpesvirinae subfamily members, the primary site for 
BHV-1 latency is sensory neurons within trigeminal ganglia (TG).  Lytic cycle viral gene 
expression (Schang et al. 1997) and infectious virus (Inman et al. 2002) are detected in 
TG during acute infection, but latency is subsequently established.  Increased 
corticosteroid levels, as a result of stress, can initiate BHV-1 reactivation from latency 
(Jones et al. 2010).  Administration of the synthetic corticosteroid dexamethasone (DEX) 
to calves or rabbits latently infected with BHV-1 reproducibly leads to reactivation from 
latency and virus shedding (Inman et al. 2002; Jones 1998; Jones 2003; Jones et al. 2000; 
Jones et al. 2006; Rock et al. 1992).  Induction of lytic cycle viral gene expression is 
consistently detected in TG neurons of calves latently infected with BHV-1 following 
DEX treatment. 
 
The BHV-1 latency related (LR) RNA is the only abundant viral transcript 
expressed in latently infected sensory neurons (Rock et al. 1987; Rock et al. 1987).  The 
LR gene contains 2 major open reading frames (ORF2 and ORF1) and two reading 
frames that lack an initiating methionine (RF-C and RF-B) (Kutish et al. 1990).  Two 
micro-RNAs encoded within the LR gene inhibit bICP0 protein expression (Jaber et al. 
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2010) and promote cell survival (da Silva et al. 2012).  A mutant BHV-1 strain with 3 
stop codons at the N-terminus of ORF-2 (LR mutant virus) does not express detectable 
levels of ORF-2 or RF-C (Jiang et al. 2004) but expresses reduced levels of ORF1 during 
productive infection of cultured cells (Meyer et al. 2007).  The LR mutant virus grows 
less efficiently in the ocular cavity or trigeminal ganglia, but does not reactivate from 
latency following DEX treatment (Inman et al. 2001; Inman et al. 2002) suggesting 
expression of LR proteins is required for the latency-reactivation cycle in cattle.  During 
establishment of latency, the LR mutant virus induces higher levels of apoptosis in TG 
neurons of infected calves (Lovato et al. 2003), and plasmids with the same stop codon 
mutations exhibit little or no anti-apoptosis activity (Ciacci-Zanella et al. 1999; 
Henderson et al. 2004).   
 
ORF2 protein expression, in the absence of other viral genes, inhibits apoptosis in 
transiently transfected cells (Shen et al. 2008) suggesting ORF2 is a dominant function 
encoded by the LR gene. ORF2 also interacts with the intracellular domain of Notch1 and 
Notch3, components of the Notch signaling pathway (Workman et al. 2011).  Notch1, but 
not Notch3 enhances BHV-1 productive infection and activates the BHV-1 immediate-
early transcription unit 1 (IEtu1) and bICP0 early promoters: whereas both Notch1 and 
Notch3 trans-activate the late BHV-1 glycoprotein C (gC) promoter.  ORF2 interferes 
with the ability of Notch1 to trans-activate the bICP0 early promoter and Notch1 or 
Notch3 mediated activation of the gC promoter (Workman et al. 2011) suggesting this 
function promotes the establishment and/or maintenance of latency. 
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Notch receptors (Notch1-4) are membrane tethered transcription factors that 
regulate differentiation and development of nearly all cell types [reviewed in (Bray 2006; 
Cornell et al. 2005; Ehebauer et al. 2006; Justice et al. 2002)].  When the Notch receptor 
is engaged by one of its five trans-membrane ligands (Jagged1, Jagged2, Delta-like1, 
Delta-like3, and Delta-like4), the Notch intracellular domain (ICD) is cleaved by specific 
proteases, the Notch ICD translocates to the nucleus, and is considered to be “active”.  
Notch ICD interacts with members of the CSL family of transcriptional repressors, 
CBF1, Su(H), or Lag1 (also referred to as RBP-jκ for mammalians) and mastermind 
(MAML).  The Notch-CSL-MAML complex binds to specific DNA sequences, RNA pol 
II co-activators are recruited to the Notch-CSL-MAML complex, and consequently 
transcription occurs (Bray 2006; Ehebauer et al. 2006).  In the absence of an activated 
Notch family member, a CSL complex, which includes repressor proteins, inhibits 
transcription.  Activation of Notch signaling in post-mitotic-neurons or neuroblastoma 
cells inhibits neurite sprouting (Berezovska et al. 1999; Franklin et al. 1999; Levy et al. 
2002; Sestan et al. 1999) and axon repair (El Bejjani et al. 2012), which can lead to 
neuronal degeneration and apoptosis (Coleman et al. 2010; Kwok et al. 1994; Raff et al. 
2002).  Conversely, neurite sprouting correlates with regeneration of damaged axons and 
dendrites (El Bejjani et al. 2012).  During neural development, activation of Notch is 
crucial for maintaining neuro-progenitors and suppressing neuronal differentiation 
(Justice et al. 2002; Montminy 1997).  Consequently, disruption of Notch1 in mice leads 
to depletion of neural progenitor cells (Daniel et al. 1998; Goldman et al. 1997).   
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In this study, we found that Notch1 or Notch3 inhibit neurite formation in serum 
arrested mouse neuroblastoma cells (Neuro-2A).  When ORF2 is co-transfected with 
Notch1 or Notch3, neurite formation is restored suggesting ORF2 impairs Notch 
dependent signaling. ORF2 also interfered with Notch mediated trans-activation of the 
promoter that encodes Hairy Enhancer of Split 5, which interferes with neurite formation 
when over-expressed.  The N-terminal domain of ORF2 and the nuclear localization 
signal in ORF2 were important for inhibiting Notch dependent signaling.  Conversely, 
mutation of five consensus protein kinase A and/or protein kinase C phosphorylation sites 
within ORF2 did not negatively affect the ability of ORF2 to impair Notch signaling.  We 
suggest that the ability of ORF2 to promote neurite formation in the presence of activated 
Notch promotes normal neural functions following infection. 
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RESULTS 
 
Expression of Notch and ORF2 in trigeminal ganglia during the latency-reactivation 
transition 
A previous study demonstrated that Notch3 RNA levels were increased in TG 
during dexamethasone induced reactivation from latency (Workman et al. 2011).  
Immunohistochemistry (IHC) was used to determine if Notch protein expression occurred 
in TG neurons during DEX induced reactivation from latency. By 90 minutes after DEX 
treatment, Notch3 positive neurons were detected in a subset of TG neurons, and by six 
hours after DEX treatment Notch3 positive neurons were readily detected (Figure 3.1.A).  
Conversely, Notch3 positive neurons were not readily detected in mock infected TG 
sections, latently infected TG, or 24 hours after DEX treatment.  Although Notch1 was 
also detected in TG after DEX treatment (Figure 3.1.B), in general fewer neurons were 
positive and it did not appear that the signal was as intense as Notch3.   
 
As a comparison, we examined ORF2 protein expression in TG samples prior to 
and during the early stages of DEX induced reactivation from latency.  Relative to mock 
infected TG sections, ORF2 was readily detected in TG sections of latently infected 
calves (Figure 3.1.C). Since LR RNA expression is reduced during DEX-induced 
reactivation from latency (Rock et al. 1992), it was not surprising to find that the number 
of ORF2 positive neurons was reduced at 1.5 or 3 hours after DEX treatment (Figure 
3.1.C).  In summary, these results provide evidence that Notch3 protein expression was 
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induced by DEX in TG neurons; in contrast, the number of neurons expressing ORF2 
was reduced. 
 
ORF2 antagonizes Notch inhibition of neurite formation in mouse neuroblastoma 
cells 
ORF2 stably interacts with Notch3 or Notch1 and these interactions impair their 
ability to stimulate viral gene expression and productive infection (Sinani et al. 2011; 
Workman et al. 2011).  Although these previous studies provided evidence that ORF2 
interferes with the ability of Notch members to stimulate viral promoters and productive 
infection, they did not address whether ORF2 influences cellular functions of activated 
Notch signaling pathways. Activation of Notch signaling in neurons also inhibits neurite 
sprouting (Berezovska et al. 1999; Franklin et al. 1999; Levy et al. 2002; Sestan et al. 
1999) and axon repair (El Bejjani et al. 2012), which can result in neuronal cell death 
(Coleman et al. 2010; Raff et al. 2002).  Conversely, neurite sprouting is synonymous to 
regeneration of damaged axons and dendrites (El Bejjani et al. 2012).  With respect to 
BHV-1 infection of sensory neurons, maintaining neuronal health is important for life-
long latency.    
 
To test whether ORF2 affects Notch functions in mammalian cells, mouse 
neuroblastoma cells (Neuro-2A) were transfected with a plasmid that expresses activated 
Notch3 and examined the effect ORF2 has on neurite formation. When Neuro-2A cells 
were transfected with a Lac Z expression vector and growth factors removed, β-Gal+ 
neurons with extended neurites were readily detected when cells were seeded at low 
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density and then serum starved for three days (Figure 3.2.A, Control panel).  As expected 
(Franklin et al. 1999; Levy et al. 2002), Notch1 or Notch3 over-expression inhibited 
neurite formation after growth factor withdrawal (Notch1 or 3 panels).  When ORF2 was 
co-transfected with the Notch1 or the Notch3 expression plasmid, β-Gal+ Neuro-2A cells 
with long neurites were frequently detected.  Approximately ½ of the β-Gal+ cells 
consistently sprouted neurites when Neuro-2A cells were co-transfected with Notch1 or 
Notch3 and ORF2, which was significantly higher relative to Neuro-2A cells transfected 
with Notch1 or Notch3 and an empty expression vector (Figure 3.2.B).   
 
To localize domains in ORF2 that interfere with Notch inhibition of neurite 
formation, the neurite formation assay was performed in Neuro-2A cells using a panel of 
mutants previously described (Sinani et al. 2011) (a schematic of the respective ORF2 
mutants is shown in Figure 2.4.A and B).  Four N-terminal transposon mutants, ORF2-
95, ORF2-134, ORF2-240 and ORF2-271, failed to restore neurite formation when 
compared to wt ORF2 (Figure 3.3.A and B). Since ORF2-95, unlike the other transposon 
mutants, expresses lower protein levels in Neuro-2A cells compared to wt (Sinani et al. 
2011), it is difficult to distinguish whether its impaired function was due to protein 
expression levels or if an essential inhibitory domain was disrupted.  The remainder of 
the transposon mutants restored neurite formation similar to wt ORF2 regardless of 
whether they were co-transfected with Notch1 or Notch3 (Figure 3.3.A and B).  The 
phosphorylation mutants, ORF2-P and ORF2-AP, but not ORF2-∆NLS, promoted neurite 
formation in the presence of Notch1 or Notch3 with similar efficiency as wt ORF2 
suggesting nuclear localization, but not the phosphorylation status of ORF2, was 
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important.  In conclusion, these studies provided evidence that ORF2 interfered with 
activated Notch1 or Notch3 signaling and promoted neurite formation in Neuro-2A cells.  
The N-terminus of ORF2 and nuclear localization of ORF2 were important for this 
function.   
 
ORF2 inhibits activation of the HES5 promoter, a downstream target of Notch  
To further examine the ability of ORF2 to interfere with Notch signaling, we 
tested whether ORF2 influences Notch mediated trans-activation of the Hairy Enhancer 
of Split 5 (HES5) promoter.  The HES family of transcription factors contains basic 
helix-loop-helix (bHLH) domains, they generally repress transcription, and Notch trans-
activates promoters of HES family members, reviewed in (Bray 2006; Cornell et al. 
2005; Ehebauer et al. 2006; Monroy et al. 2003).  Since Hes1 and Hes5 proteins are 
transcription factors that inhibit neuronal differentiation (Ohtsuka et al. 1999), examining 
the effect of ORF2 on HES5 promoter activity is relevant to the finding that ORF2 
promoted neurite formation in the presence of Notch.  A dual luciferase assay was 
performed with a reporter plasmid that contains the HES5 promoter upstream of the 
firefly luciferase gene.  Increasing amounts of Notch1 (Figure 3.4.A) and Notch3 (Figure 
3.4.B) increased HES5 promoter activity in a dose dependent fashion.  In general, Notch1 
is a more efficient trans-activator than Notch3 (Monroy et al. 2001), which is consistent 
with our results.  
 
Neuro-2A cells were co-transfected with plasmids expressing ORF2, Notch1 or 
Notch3, the HES5 promoter and luciferase activity measured at 48 hours after 
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transfection to test whether ORF2 influenced trans-activation of the HES5 promoter by 
Notch1 or Notch3.  ORF2 consistently inhibited Notch1 dependent trans-activation of the 
HES5 promoter by 4 fold, which was significantly different when compared to the empty 
vector control (Figure 3.4.C).  ORF2 also reduced the ability of Notch3 to trans-activate 
HES5 promoter activity in a dose-dependent fashion (Figure 3.4.D).  
 
Additional studies were performed to identify ORF2 mutants that interfere with 
the ability of Notch to trans-activate its target genes.  The effects of the respective ORF2 
mutants on Notch1 or Notch3 mediated activation of HES5 promoter was analyzed.  
Surprisingly, all of the transposon mutants inhibited Notch1 and Notch3 activation of 
HES5 promoter similar to wt ORF2.  In contrast, three ORF2 mutants, ORF2-∆NLS and 
ORF2-P and ORF2-AP phosphorylation mutants, were unable to significantly interfere 
with Notch mediated transactivation of the HES5 promoter when compared to the empty 
vector (Figure 3.5). In summary, these results confirmed that ORF2 has the potential to 
interfere with the functional properties of activated Notch1 or Notch3.   
 
ORF2 promotes Notch3 degradation 
 Studies were subsequently performed to test whether ORF2 influenced the steady 
state levels of Notch3.  The rationale for this study is the assembly of the Notch/CSL 
complex at a promoter results in recruitment of the cyclin-dependent kinase-8 
(CDK8)/cyclin C complex (Johannsen et al. 1996).  CDK8/cyclin C phosphorylates 
Notch and phosphorylated Notch is a substrate for the nuclear E3 ubiquitin ligase Sel10.  
Sel10 interacts with the C-terminal PEST region of Notch, and this is required for 
107 
 
proteasomal-dependent degradation. When Notch is degraded, the co-activator complex 
dissociates from CSL leading to the recruitment of a co-repressor complex and repression 
of gene expression.  
 
To examine whether ORF2 had an effect on Notch3 steady state levels, co-
transfection studies were performed and Notch3 protein levels examined by Western Blot 
analysis.  Cells were also treated with cycloheximide (CHX) to block de novo protein 
synthesis. In the absence of ORF2, Notch3 levels were reduced within 2 hours after CHX 
treatment unless the proteasome inhibitor lactacystin was added to cultures (Figure 7A).  
In the presence of ORF2, Notch3 protein levels were consistently less than the empty 
vector control, even before CHX treatment (Figure 3.6.A).  One hour after CHX 
treatment, the levels of Notch3 were also reduced in cells co-transfected with ORF2 when 
compared to the empty vector.  This effect was dependent on the ORF2 protein because a 
frameshift mutant that expresses mRNA but not protein (2A/ORF2) had no effect on 
Notch3 stability (Figure 3.6.B)  
 
To identify ORF2 sequences that influence Notch3 stability, Neuro-2A cells were 
co-transfected with the Notch3 expression plasmid plus the designated ORF2 mutants 
and western blot was performed to examine Notch protein levels.  Three transposon 
mutants that did not stimulate neurite formation (ORF2-134, ORF2-240, and ORF2-271) 
and one that behaved like wt (ORF2-529) were used for these studies.  ORF2-240, but 
not the other transposon mutants, had slightly higher levels of Notch3 when compared to 
wt ORF2 (Figure 3.6.C).  The ORF2-NLS mutant, but not the two phosphorylation 
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mutants, had little or no effect on Notch3 protein stability (Figure 3.6.D). These studies 
indicated that ORF2 reduced the half-life of Notch3 and that nuclear localization of 
ORF2 was necessary for this function. 
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DISCUSSION 
 
In this study, we demonstrated that expression of ORF2 in Neuro-2A cells 
restored neurite formation in the presence of Notch1 or Notch3.  As expected, Notch1 or 
Notch3 interferes with neurite formation in serum-arrested Neuro-2A cells (Berezovska 
et al. 1999; Franklin et al. 1999; Levy et al. 2002; Sestan et al. 1999).  Previous studies 
demonstrated that ORF2 interfered with the ability of Notch1 and Notch3 to activate 
productive infection and trans-activate certain viral promoters (Workman et al. 2011). 
Since these studies did not test whether ORF2 influenced the ability of Notch to regulate 
known cellular functions, it was important to test whether ORF2 influenced cellular 
functions of Notch signaling. Since activated Notch is required for the growth of certain 
human tumors (Armstrong et al. 1961; Bosch et al. 1999; El-Serag 2004), ORF2 may 
also have therapeutic value with respect to inhibiting the growth of tumors that are 
dependent on Notch for proliferation.  
 
 Many other genes, in addition to Notch, negatively regulate neurite sprouting.  
These include, A1 adenosine receptor, merlin, adenomatous polyposis coli protein, β-
catenin, Cdc42-interacting protein 4, harmine, HES-1, HES-5, proline/serine-rich coiled-
coil protein 1 (also known as DDA3), and Van Gogh 1 (Cai et al. 2003; Doyon et al. 
2004; Kalamvoki et al. 2004; Moradpour et al. 2004; Ogawa et al. 2003; Ohtsuka et al. 
1999; Polesskaya et al. 2000; Polesskaya et al. 2001; Satoh et al. 2000).  Conversely, a 
number of genes promote neurite sprouting.  For example, a complex containing 
diacylglycerol kinase , Rac1, and syntrophin promotes neurite outgrowth (Nakajima et 
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al. 1997; Swope et al. 1996).  In addition, the Brn-3a transcription factor, CD47 (also 
referred to as integrin-associated protein), degenerin/epithelial Na
+
 channel protein, 
Dickkopf-1, insulin–like growth factors I and II, NF-κB, plasticity-related gene 5, Prickle 
1 or 2 genes, protruding, retina derived growth factor, and Wnt-3a promote neurite 
outgrowth (Boyes et al. 1998; Chen et al. 2007; Foehr et al. 2000; Fuchs et al. 2001; 
Hung et al. 1999; Ogryzko et al. 1996; Oswald et al. 2001; Sakaguchi et al. 1998; Sano 
et al. 2001; Wallberg et al. 2002).  Several proteins that positively or negatively regulate 
neurite outgrowth belong to the Wnt signaling pathway (adenomatous polyposis coli 
protein, β-catenin, Wnt-3a, and Dickkopf-1).  The Wnt and Notch signaling pathway 
have considerable cross-talk and thus activating or repressing the Notch signaling 
pathway impacts Wnt signaling (Kopan et al. 2009; Song et al. 2000).  It is not clear 
whether ORF2 influences the Wnt signaling pathway, and/or other genes that regulate 
neurite outgrowth.   
 
There was a nice correlation between the ability of the respective ORF2 mutants 
to inhibit Notch activation of certain BHV-1 promoters and productive infection and 
Notch inhibition of neurite formation, however the effect of ORF2 mutants on Notch 
activation of the HES5 promoter differed. Two phosphorylation mutants (ORF2-P and 
ORF2-AP) did not effectively inhibit Notch mediated trans-activation of the HES5 
promoter whereas the same mutants promoted neurite formation and inhibited Notch 
activation of BHV-1 promoters and productive infection with wild-type efficiency.  In 
contrast, the ORF2 N-terminal mutants that fail to restore neurite growth blocked by 
Notch expression and are unable to inhibit Notch1 mediated trans-activation of the bICP0 
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early promoter were able to inhibit Notch activation of HES5 promoter similar to wt 
ORF2 (Sinani et al. 2011). This suggests ORF2 has differential effects on Notch 
mediated trans-activation.  For activated Notch to stimulate transcription, Notch, CSL, 
and MAML form a complex at a consensus CSL binding site, reviewed in (Bray 2006; 
Ehebauer et al. 2006).  Consequently, ORF2 may: 1) interfere with the formation of the 
Notch/CSL/MAML complex, 2) influence the Notch/CSL/MAML complex from 
interacting with certain CSL consensus binding sites, or 3) interfere with certain co-
activators recruited to the Notch-CSL-MAML complex, (Bray 2006; Ehebauer et al. 
2006).  The finding that ORF2 reduced the steady state levels of Notch3 would also 
interfere with the trans-activation potential of Notch3.  We speculate that the ORF2 
phosphorylation mutants influence trans-activation of the bICP0 early promoter but not 
the HES5 promoter.  Since the ORF2 phosphorylation mutants are more stable than 
ORF2 (Sinani et al. 2011), the differential effects of inhibiting Notch mediated trans-
activation were not merely due to lower levels of mutant ORF2 in transfected cells.  
Additional studies are necessary to understand the mechanism by which ORF2 and the 
phosphorylation mutants interfere with Notch mediated trans-activation of promoters.  
 
ORF-2, in the absence of other viral genes, inhibits apoptosis (Shen et al. 2008; 
Sinani et al. 2011) in transiently transfected cells.  We predicted that the anti-apoptosis 
functions of ORF2 are crucial for the latency-reactivation cycle because a LR mutant 
virus that contains stop codons at the amino-terminus of ORF2 induces higher levels of 
apoptosis in TG neurons during establishment of latency (Lovato et al. 2003) does not 
reactivate from latency after dexamethasone treatment (Inman et al. 2002).  The finding 
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that ORF2 promotes neurite formation in the presence of Notch may maintain normal 
neuronal functions, including enhancing survival, after infection.  BHV-1 productive 
infection induces Notch1 protein levels (Workman et al. 2011) suggesting that during the 
establishment of latency ORF2 ensures that infected neurons maintain axonal projections 
by promoting neurite sprouting in the presence of activated Notch.  In the absence of 
ORF2 (LR mutant virus for example), we predict that certain infected neurons are more 
susceptible to loss of axonal projections because activated Notch is present.  It is well 
established that neurons in which their axons have been damaged or cut can undergo 
Wallerian degeneration, a slow form of neuronal death suggesting that ORF2 may protect 
infected and damaged neurons from Wallerian cell death (Coleman et al. 2010; 
Robertson et al. 1995).  The fact that Notch stimulates productive infection (Workman et 
al. 2011) also favors virus induced neuronal cell death.  In neuronal progenitor cells, 
Notch activation induces apoptosis by a p53-dependent pathway (Kwok et al. 1994).  
Activated Notch also interferes with neuronal differentiation in the ophthalmic branch of 
trigeminal ganglia (Tamura et al. 1995) adding further support that that ORF2 may 
promote latency by interfering with Notch dependent signaling in sensory neurons.  
Collectively, these observations, suggest that the ability of ORF2 to restrain Notch 
functions promotes the establishment and maintenance of life-long latency.  
 
During dexamethasone induced reactivation from latency, Notch3 RNA levels are 
induced (Workman et al. 2011) and HES6 is induced within six hours after 
dexamethasone treatment (Workman et al. 2012). Examination of dexamethasone 
induced transcription in trigeminal ganglia of calves latently infected with neurons 
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revealed that many genes activated by Notch signaling are induced (data not shown) 
suggesting that the Notch signaling pathway enhances reactivation from latency or is 
merely activated by dexamethasone.  Since ORF2 protein expression is reduced during 
dexamethasone induced reactivation, Notch family members would not be restrained by 
ORF2 suggesting Notch destabilizes normal neuronal functions and may even induce 
neuronal apoptosis. 
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FIGURES 
 
Figure 3.1: Expression of Notch and ORF2 in the TG  
TG were collected from calves that were mock infected, latently infected (at least 60 days 
post infection), or latently infected and treated with dexamethasone at the indicated time 
points to induce reactivation from latency.  Thin sections were cut and subjected to 
immunohistochemistry with either Notch3 (Panel A), Notch1 (Panel B) or ORF2 (Panel 
C) as described in the materials and methods. Biotinylated goat anti-rabbit IgG was used 
as a secondary antibody. Thin sections from mock-infected calves were used as a 
negative control. Black arrows indicate positive neurons. 
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Figure 3.2:  ORF2 antagonizes Notch inhibition of neurite formation  
Panel A: Neuro-2A cells were co-transfected with a plasmid expressing the Notch1 or 
Notch3 intracellular domain, a plasmid expressing ORF2, and a plasmid expressing the 
Lac Z gene (transfection control). To induce neurite sprouting, 24 hours after 
transfection, cells were seeded into new plates at a low density of 2000 cells/cm
2
 and 
were starved in media with 0.5% serum for three days. Cells were then fixed, stained and 
the β-gal assay was performed as described in the materials and methods.   
Panel B: The percent of β-Gal+ cells containing neurites was calculated by dividing the 
number of β-gal+ cells with a neurite length at least twice the diameter of the cell by the 
total number of β-gal+ cells. The average of at least 3 independent experiments is shown 
with the respective standard deviation. 
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Figure 3.2: 
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Figure 3.3:  Localization of ORF2 sequences necessary to inhibit neurite formation 
in the presence of Notch1 or Notch3  
Neuro-2A cells were co-transfected with a plasmid expressing the intracellular domain of 
Notch1 (Panel A), or Notch3 (Panel B), a plasmid expressing WT or the designated 
mutant ORF2 construct, and a plasmid expressing Lac Z.  Neurite formation was 
calculated as described in Figure 3.2. The results represent the average of at least 3 
independent experiments with the respective standard deviation. 
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Figure 3.4:  ORF2 interferes with Notch mediated trans-activation of the HES5 
promoter  
Neuro-2A cells were co-transfected with a plasmid containing the Firefly luciferase gene 
downstream of the HES5 promoter, a plasmid expressing Notch1 (Panels A, C) or 
Notch3 (Panels B, D) intracellular domain and increasing amounts of a plasmid 
expressing ORF2 (Panels C, D). Promoter activity was measured using a dual luciferase 
assay. A plasmid expressing Renilla luciferase under control of the herpesvirus TK 
promoter was used as an internal control. The results are an average of at least three 
independent experiments with the respective standard deviation. 
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- 0.1  0.25  0.5    1     2  Notch1
F
o
ld
 A
c
ti
v
a
ti
o
n
0
40
80
120A
- +      +     +      +      +
- - 0.5    1   1.5     2 
Notch1
ORF2
F
o
ld
 A
c
ti
v
a
ti
o
n
0
25
50
75C
F
o
ld
 A
c
ti
v
a
ti
o
n
0
15
30
45
60
- 0.1  0.25  0.5    1     2  Notch3
B
- +     +    +     +     +Notch3
F
o
ld
 A
c
ti
v
a
ti
o
n
0
4
8
12
- - 0.5    1    1.5     2 ORF2
D
122 
 
Figure 3.5:  Localization of ORF2 sequences important for Notch1 and Notch3 
mediated trans-activation of the HES5 promoter  
Neuro-2A cells were co-transfected with a plasmid expressing the intracellular domain of 
Notch1 (Panel A) or Notch3 (Panel B), a plasmid expressing WT or mutant ORF2, and a 
plasmid containing the Firefly luciferase gene downstream of the HES5 promoter. 
Luciferase assay was performed as described in Figure 5. The results represent the 
average of at least three independent experiments with the respective standard deviation. 
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Figure 3.5: 
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Figure 3.6:  ORF2 reduces the steady state levels of Notch3   
Panel A: Neuro-2A cells were transfected with the designated plasmids then collected 
and processed for western blot.  Cultures were treated with 100 μM CHX for one or two 
hours forty hours after transfection. To inhibit proteasome activity, cells were treated 
with Lactacystin (15 µM) 10 hours prior to CHX treatment.  
Panel B: The plasmid 2A/ORF2 contains ORF2 cloned such that there is a one-
nucleotide frame shift with respect to the N-terminal Flag epitope.  The plasmid 
2B/ORF2 contains ORF2 in frame with the N-terminal Flag epitope.   
Panel C and D:  The effects of the respective ORF2 mutants on Notch3 steady state 
protein levels were examined.  Neuro-2A cells were co-transfected with ORF2 or the 
designated ORF2 mutants and the plasmid expressing Notch3.  Cultures were treated 
with CHX as described above.  A mouse anti-Flag antibody was used to detect wt and 
mutant ORF2 while Notch3 was detected using a rabbit anti-Notch3 antibody. Goat anti-
Actin was used to confirm equal protein loading. 
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Figure 3.6: 
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CHAPTER IV 
 
A protein (ORF2) encoded by the latency related gene of bovine herpesvirus 1 
interacts with DNA 
 
The studies in this chapter are included in a manuscript submitted to the Journal of 
Virology 
 
Authors 
are 
 
Devis Sinani, Daraporn Pittayakhajonwut, and Clinton Jones   
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ABSTRACT 
 
Bovine herpes virus 1 (BHV-1), as other alpha-herpesvirinae subfamily members, 
establishes latency in sensory neurons.  The viral encoded latency-related RNA (LR-
RNA) is abundantly expressed in latently infected sensory neurons, and encodes several 
proteins, including ORF2, as well as two micro-RNAs.  A LR mutant virus with stop 
codons at the amino-terminus of ORF2 does not reactivate from latency after 
dexamethasone treatment, in part, due to increased apoptosis during the establishment of 
latency.  ORF2 inhibits apoptosis, interacts with three cellular transcription factors 
(Notch1, Notch3, and C/EBP-alpha), and interferes with Notch mediated trans-activation 
of certain viral promoters.  These observations suggest that ORF2 expression is crucial 
for the latency-reactivation cycle in cattle.  In this study, we identified a 29 amino acid 
domain within ORF2 that resembles three cellular transcription factors (SP5, SP8, and 
general transcription factor II F, polypeptide 2).  ORF2 is comprised of over 20% basic 
amino acids suggesting ORF2 interacts with nucleic acids.  A subset of ORF2 was 
associated with chromatin and preferentially associated with single stranded DNA in 
transfected mouse neuroblastoma cells (Neuro-2A).  Alanine substitution of serine, 
threonine, and tyrosine residues in ORF2 led to a protein that had increased steady state 
levels in Neuro-2A cells, and a protein that preferentially interacted with double stranded 
DNA.  ORF2 partially purified from bacteria under denaturing conditions preferentially 
interacted with double stranded DNA.  In contrast, ORF2 purified under native conditions 
preferentially interacted with single stranded DNA.  We suggest that interactions between 
ORF2 and DNA play a role in regulating certain aspects of the latency-reactivation cycle.   
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INTRODUCTION 
 
Bovine herpesvirus 1 (BHV-1), an alpha-herpesvirinae subfamily member, causes 
significant economical losses to the cattle industry (Turin et al. 1999).  For example, the 
ability of BHV-1 to suppress the immune system can result in life-threatening bacterial 
pneumonia.  This multi-factorial disorder is referred to as the bovine respiratory disease 
complex {reviewed in (Jones 2009; Jones et al. 2007)}.  When acute infection occurs on 
mucosal linings within the ocular, nasal, or oral cavity, sensory neurons within trigeminal 
ganglia (TG) become the primary site for BHV-1 latency.  Abundant viral gene 
expression (Schang et al. 1997) and infectious virus (Inman et al. 2002) are detected 
during acute infection, but viral gene expression is extinguished and latency is 
established (Jones et al. 2007; Jones et al. 2006).  Stress (due to confinement, 
transporting cattle, restricting food and water, or weaning) increases corticosteroid levels, 
and can initiate reactivation from latency (Jones et al. 2010).  Administration of the 
synthetic corticosteroid dexamethasone to calves latently infected with BHV-1 
reproducibly induces reactivation from latency (Inman et al. 2002; Jones 1998; Jones 
2003; Jones et al. 2000; Jones et al. 2006; Rock et al. 1992).  Induction of lytic cycle 
viral gene transcription is also consistently detected in TG neurons of calves latently 
infected with BHV-1 following dexamethasone treatment.    
 
Abundant expression of the BHV-1 encoded latency related (LR) RNA occurs in 
latently infected neurons, however infectious virus is not detected by standard virological 
assays (maintenance of latency) (Jones 1998; Jones 2003; Jones et al. 2006; Kutish et al. 
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1990; Rock et al. 1992; Rock et al. 1987).  LR-RNA is anti-sense relative to the bICP0 
gene and has a unique start site in TG (Bratanich et al. 1992; Hossain et al. 1995).  The 
LR gene has two open reading frames (ORF1 and ORF2) and two reading frames that 
lack an initiating ATG (RF-B and RF-C).  A LR mutant virus strain with 3 stop codons at 
the N-terminus of ORF2 exhibits diminished clinical symptoms, and reduced virus 
shedding from the eye, TG, or tonsils of infected calves (Inman et al. 2001; Inman et al. 
2002; Perez et al. 2005).  ORF1, ORF2, and RF-C are expressed when bovine cells are 
infected with wt or the LR rescued virus, but have reduced or no expression following 
infection with the LR mutant virus (Jiang et al. 2004; Meyer et al. 2007).  Wt LR gene 
expression is necessary for Dexamethasone (DEX) induced reactivation from latency 
(Inman et al. 2002), in part, because the anti-apoptosis activity of ORF2 appears to be 
crucial for the latency-reactivation cycle (Ciacci-Zanella et al. 1999; Lovato et al. 2003; 
Shen et al. 2008; Sinani et al. 2011).  Additional studies demonstrated that ORF2 
interacts with cellular transcription factors, Notch1, Notch3, or C/EBP-alpha (Meyer et 
al. 2008; Meyer et al. 2007; Workman et al. 2011).  ORF2 reduces Notch mediated trans-
activation of the bICP0 early promoter and glycoprotein C promoter in transient 
transfection assays providing evidence that ORF2, in part, maintains latency by 
interfering with viral transcription.  Distinct non-overlapping sequences within ORF2 are 
important for inhibiting apoptosis versus Notch mediated trans-activation of the bICP0 
early promoter (Sinani et al. 2011).  Additionally, the ability of LR-specific micro-RNAs 
to inhibit bICP0 expression and regulate the RNA sensor (RIG-I) may enhance life-long 
latency in cattle by interfering with productive infection and promoting neuronal survival 
(da Silva et al. 2012; Jaber et al. 2010). 
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In this study, we identified a 29 amino acid domain in ORF2 resembling cellular 
transcription factors that specifically bind GC rich DNA sequences (Sp5 and Sp8).  ORF2 
extracted from mouse neuroblastoma cells preferentially interacted with single stranded- 
(ss) DNA cellulose compared to double stranded- (ds) DNA cellulose.  In contrast, a 
mutant ORF2 protein with alanine substitutions of all amino acids that can be 
phosphorylated interacts preferentially with ds-DNA.  A similar result was observed 
when only five consensus protein kinase A (PKA) and/or PKC phosphorylation sites 
were mutated to alanine.  ORF2 partially purified under denaturing conditions from E. 
coli preferentially interacted with double stranded ds-DNA cellulose while ORF2 
partially purified under non-denaturing conditions preferentially interacted with ss-DNA 
cellulose.  When ORF2 was purified from bacteria under denaturing conditions, ds-DNA, 
but not total RNA, inhibited binding to ds-DNA cellulose.  Collectively, these studies 
provide evidence that ORF2 interacts with DNA suggesting this function could play a 
potential role in the latency-reactivation cycle. 
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RESULTS 
 
ORF2 is a basic protein containing a domain similar to certain cellular transcription 
factors 
ORF2 is the first open reading frame downstream of the start site of LR-RNA 
(Figure 4.1.A), the coding sequences of ORF2 completely overlap the bICP0 transcript, 
and ORF2 is expressed in a subset of latently infected neurons (Jiang et al. 1998; Jones et 
al. 2011).  ORF2 contains over 20% basic amino acids (black shaded amino acids), and 5 
consensus protein kinase A (PKA) or PKC phosphorylation sites (grey shaded amino 
acids) (Figure 4.1.B).  BLAST analysis of the entire ORF2 did not reveal significant 
similarity to known proteins.  However, BLAST analysis of a 29 amino acid motif in 
ORF2 that contain the nuclear localization signal (NLS), a PKA phosphorylation site at 
amino acid 71 and six basic amino acids (Figure 4.1.B, underlined amino acids) revealed 
this domain is similar to three transcription factors (Sp5, Sp8, and general transcription 
factor IIF, polypeptide 2).  The nuclear localization signal (NLS) within ORF2 is 
identical to the NLS in the transcription factor Sp1 (Devireddy et al. 2003) and deletion 
of amino acids comprising the ORF2 NLS prevents nuclear localization (Sinani et al. 
2011).  The transcription family that includes Sp1, Sp5, and Sp8 bind GC rich consensus 
DNA binding sites, reviewed in (Bouwman et al. 2002).  Sp5 and Sp8 are known to 
regulate forebrain development, neuropore closure, and development of olfactory bulb 
inter-neurons (Bell et al. 2003; Waclaw et al. 2006; Weidinger et al. 2005; Zembrzycki et 
al. 2007).  Collectively, these observations suggested that ORF2 could potentially interact 
with nucleic acids. 
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Analysis of ORF2 in transfected cells 
 Two phosphorylation mutants of ORF2 were synthesized:  ORF2-AP contains 
alanine mutations in all serine, threonine, and tyrosine residues, and ORF2-P contains all 
of the PKA/PKC consensus sites mutated to alanine (Sinani et al. 2011).  ORF2-P also 
contains mutations in Tyr39 and Ser120, which are adjacent to PKA/PKC sites.  In 
transfected Neuro-2A cells (Figure 4.1.C), wt ORF2 migrated as a 20 and 30 kd band 
(Figure 4.1.C; closed circles).  The ORF2-AP and ORF2-P mutant proteins were 
expressed at higher steady state levels relative to wt ORF2 (open arrow), which is 
consistent with a recent study (Sinani et al. 2011).  This could be because 
phosphorylation of ORF2 might play a role in the half-life of ORF2 or the protein 
changes conformation so that the anti-Flag antibody better recognizes the Flag-tag. 
However, since the antibody is at the N-terminus of ORF2 the change in ORF2 half-life 
is the more plausible explanation. The predominant band expressed by ORF2-AP and 
ORF2-P migrated near 24 kd, and was the only band detected unless the blot was over-
exposed to allow detection of wt ORF2.  The predicted molecular weight of ORF2 is 
approximately 19 kd.  In cells transfected with the blank expression vector, the Flag 
specific antibody did not readily detect specific bands.   
 
 When expressed in Neuro-2A cells, ORF2 localizes to the nuclear periphery 
(Figure 4.2.A) (Sinani et al. 2011; Workman et al. 2011). The phosphorylation mutants, 
ORF2-AP or ORF2-P, appear to have similar nuclear localization as wt ORF2 when 
visualized by confocal microscopy (Figure 4.2.A).  To further examine the localization of 
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ORF2 in transfected cells, biochemical fractionation of transfected cells was performed 
and compared to a protein known to localize to the nucleus, cyclin dependent kinase 2 
(cdk2).  Treatment of cells with .15 M NaCl released most of ORF2 and cdk2 (Figure 
4.2.B).  Readily detectable levels of wt ORF2 were also released from the nucleus after 
DNAse I treatment.  In contrast to cdk2, ORF2 was readily detected in the nuclear pellet 
even after RIPA buffer treatment.  In general, the alanine substitution mutants (ORF2-P 
and ORF2-AP) contained less protein in the nuclear pellet but more protein was released 
from nuclei after treatment with DNAse I and RIPA buffer.  The relative levels of the 33 
kd ORF2 specific band varied from experiment to experiment, and the fact that this 
higher molecular weight band was not detected in cells transfected with ORF2-P or 
ORF2-AP adds support to the concept that ORF-2 specific high molecular weight bands 
were the result of phosphorylation.   
 
The relative amount of ORF2 in the respective samples were estimated by 
measuring ORF2 protein levels in the gel and comparing these values to the total amount 
of protein in the respective nuclear fraction (Figure 4.2.C).  When the phosphorylation 
mutants were compared to wt ORF2, the major difference was higher levels of protein 
was released by DNAse I and RIPA buffer.  In summary, these studies confirmed that 
ORF2 was localized to the nucleus and that phosphorylation of ORF2 has subtle effects 
on sub-nuclear localization. 
 
ORF2 expressed in Neuro-2A cells interacts with DNA 
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Release of ORF2 from transfected cells by DNAse I treatment added support to the 
prediction that ORF2 interacts with DNA or structures containing DNA.  To test whether 
ORF2 interacted with DNA, Neuro-2A cells were transfected with a Flag-tagged ORF2 
expressing plasmid, ORF2 extracted from transfected cells, extracts incubated with DNA 
cellulose beads, and retention of ORF2 to DNA cellulose beads detected by Western blot 
analysis using a Flag specific monoclonal antibody.  In several independent studies, 
ORF2 preferentially interacted with ss-DNA beads relative to ds-DNA beads or blank 
cellulose beads (Figure 4.3.A).  As expected, ORF2 specific bands were not detected by 
the Flag monoclonal antibodies in mock-transfected cells (Figure 4.3.A, Mock lanes).  In 
contrast to wt ORF2, ORF2-AP (Figure 4.3.B) or ORF2-P (Figure 4.3.C) phosphorylation 
mutants preferentially interacted with ds-DNA cellulose.  In summary, this study 
provided evidence that wt ORF2 preferentially interacted with ss-DNA whereas both 
ORF2 phosphorylation mutants preferentially interacted with ds-DNA. 
 
ORF2 partially purified from bacteria interacts with DNA 
Although the studies in Figure 3 indicated that ORF2 interacted with DNA, the fact 
that ORF2 interacts with three cellular transcription factors, Notch1, Notch3, and c/EBP-
alpha (Meyer et al. 2007; Workman et al. 2011) suggested that the interaction between 
ORF2 and DNA may occur by an indirect mechanism.  To address this concern, 
Daraporn Pittayakhajonwut over-expressed a His-tagged ORF2 in E. coli, purified this 
protein, and performed DNA chromatography.  She found that when purified under 
native conditions, ORF2 preferentially interacted with ss-DNA while under denaturing 
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conditions, it preferentially interacted with ds-DNA cellulose. This interaction could be 
competed with herring DNA but not with yeast RNA. 
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DISCUSSION 
 
In this study, we have provided evidence that ORF2, in the absence of other viral 
proteins, stably associates with DNA.  It seems unlikely that the interaction between 
ORF2 and DNA was due to ORF2 interacting with cellular DNA binding proteins 
because ORF2 interacted with DNA even after it was partially purified from bacteria 
under denaturing conditions.  Curiously, purifying ORF2 from bacteria under non-
denaturing conditions led to a protein that preferentially interacted with ss-DNA, which 
was similar to wt ORF-2 extracted from transfected Neuro-2A cells.  Substituting serine 
or threonine residues in the consensus PKA/PKC phosphorylation sites in ORF2 to 
alanine strongly enhanced the ability of ORF2 to interact with ds-DNA, which was 
similar to ORF2 purified from bacteria under denaturing conditions.  These results 
suggested that conformational and/or the charge of ORF2 influenced its ability to interact 
with ds- versus ss-DNA.  Although these alanine substitution mutants exhibited a higher 
steady state protein level in transfected cells, they inhibit apoptosis and Notch mediated 
trans-activation of the bICP0 early promoter with similar efficiency as wt ORF2 (Sinani 
et al. 2011).  It will be informative to identify which ORF2 amino acids, if any, are 
phosphorylated in sensory neurons of latently infected calves and if differences exist 
relative to productive infection or transient transfection.  
 
The finding that a 29 amino acid motif in ORF2 was similar to two cellular 
transcription factors that specifically bind DNA (Sp5 and Sp8) suggested that ORF2 
could potentially bind DNA.  To date, we have no evidence indicating ORF2 binds DNA 
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in a sequence specific fashion.  However, we cannot rule out the possibility that ORF2 
can bind specific DNA sequences in the presence of a neuronal factor or by specific post-
translational modifications.  It is also possible that ORF2 preferentially binds a broad-
based consensus sequence that is frequently present in the viral genome.  Attempts to 
generate ORF2 deletion mutants to localize the DNA binding domain of ORF2 because 
proteins encoded by the deletion mutants were not stable in bacteria or in transiently 
transfected Neuro-2A cells.  These negative results suggest that the ½ life of ORF2 is 
tightly regulated and may have functional significance.  
 
Previous studies suggested ORF2 is a crucial function encoded by the LR gene 
that promotes the latency-reactivation cycle, reviewed in (Jones et al. 2011).  For 
example, a LR mutant virus containing stop codons at the N-terminus of ORF2 induces 
higher levels of apoptosis in sensory neurons during the establishment of latency (Lovato 
et al. 2003), but the LR mutant virus does not reactivate from latency following 
dexamethasone treatment (Inman et al. 2002).  Consequently, the ability of ORF2 
(Ciacci-Zanella et al. 1999; Shen et al. 2008; Sinani et al. 2011) to inhibit apoptosis is 
proposed to promote the survival of infected sensory neurons, in particular during the 
establishment of latency (Lovato et al. 2003).  The ability of ORF2 to interact with 
cellular transcription factors, Notch1, Notch3, and C/EBP-alpha for example (Meyer et 
al. 2007; Workman et al. 2011) also appears to be important during the latency-
reactivation cycle.  These interactions reduced the ability of Notch1 to stimulate 
productive infection and the ability of Notch1 or Notch3 to trans-activate certain viral 
promoters (Workman et al. 2011).  Furthermore, C/EBP-alpha cooperates with the BHV-
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1 VP16 homologue to trans-activate viral immediate early promoters (Meyer et al. 2008) 
suggesting that an interaction between ORF2 and C/EBP-alpha reduces immediate early 
gene expression.  Finally, support for ORF2 playing a role in the latency-reactivation 
cycle comes from studies demonstrating that the wt LR gene, but not the ORF2 mutated 
LR gene, restores wt reactivation levels to a HSV-1 LAT null mutant (Mott et al. 2003; 
Perng et al. 2002).  Although ORF2 is an important regulator of the latency-reactivation 
cycle, the LR gene encodes for several functions suggesting that all of these products 
play a role in the life-long latency-reactivation cycle.  For example, the LR gene encodes 
two micro-RNAs that interfere with bICP0 expression and promote cell survival (da Silva 
et al. 2012; Jaber et al. 2010) as well as other proteins with unknown functions (Jiang et 
al. 2004; Meyer et al. 2007). 
 
The finding that ORF2 is tightly associated to the nuclear periphery in transiently 
transfected cells (Sinani et al. 2011; Workman et al. 2011) and that ORF2 interacts with 
ss- and ds-DNA implies that ORF2 recruits the viral genome to certain sub-nuclear 
structures in latently infected neurons.  Several studies have concluded that if genes are 
localized to the nuclear periphery or nuclear envelope gene expression is reduced or 
silenced (Finlan et al. 2008; Green et al. 2012; Shaklai et al. 2007; Vande Vosse et al. 
2011).  The organization of genes at the nuclear periphery or nuclear envelope can also 
lead to activation depending on factors located at these respective specific sites, reviewed 
in (Akhtar et al. 2007).  In general, it appears that genes close to the nuclear pore are 
more active than compared to when they are located further from the nuclear pore.  A 
yeast protein, enhancer of silent chromatin 1, localizes to the nuclear peripheral areas 
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much like ORF2, and the enhancer of silent chromatin 1 protein recruits heterochromatin 
to the nuclear periphery (Andrulis 2001; Gatenberg 2000; Taddei et al. 2004).  If ORF2 
recruits viral genomes to the nuclear periphery, this would interfere with viral genomes 
entering replication compartments in infected sensory neurons and consequently promote 
the establishment and/or the maintenance of latency.  ORF2 does not regulate basal levels 
of the bICP0 early promoter, the immediate early promoter that activates bICP4 and 
bICP0 expression, or the glycoprotein C promoter in transient transfection assays (Sinani 
et al. 2011; Workman et al. 2011) suggesting that ORF2 is not a sequence-specific 
repressor of transcription. Conversely, our studies suggest that ORF2 regulates gene 
expression by sequestering specific cellular transcription factors, and this function does 
not appear to require sequence specific binding of ORF2 to DNA.  Studies designed to 
understand the precise role that the DNA binding properties of ORF2 play in the latency-
reactivation cycle of BHV-1 are underway. 
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FIGURES 
 
Figure 4.1:  Schematic of LR gene and expression of ORF2 in transfected neuro-2A 
cells 
Panel A:  Schematic of the LR gene. Partial restriction map of the LR gene is shown.  
The numbering system of the LR gene and position of ORF2 was derived from a previous 
study (Kutish et al. 1990).  The location of LR-RNA start sites was previously published 
(Bratanich et al. 1992; Hossain et al. 1995).  The position of the 3’ terminus of bICP0 
and the bICP0 stop codon was previously described (Wirth et al. 1992; Wirth et al. 1989; 
Wirth et al. 1991). 
Panel B:  Amino acid sequence of ORF2.  The black shaded amino acids are basic amino 
acids, the underlined amino acids contain the NLS, and the grey amino acids are the 
threonine or serine residues that are within consensus PKA or PKC phosphorylation sites.   
Panel C:  Neuro-2A cells were transfected with the wt ORF2 construct, the ORF2-AP 
construct, or the ORF-P construct. At 48 hours after transfection, cell lysate was prepared 
and wt or mutant ORF2 detected by Western blotting using a Flag-specific monoclonal 
antibody. 
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Figure 4.2:  Localization of WT ORF2 in Neuro-2A cells 
Panel A: Neuro-2A cells were transfected with the designated plasmids that express 
Flag-tagged wt or mutant ORF2.  Cultures were prepared for confocal microscopy at 48 
hours after transfection as described in the materials and methods. Anti-Flag antibody 
(red) and DAPI (blue) were used to visualize wt or mutant ORF2 and the nucleus 
respectively.  DIC (differential interference contrast) was used to show the unstained 
cells. The images are representative of more than 3 independent experiments. 
Panel B: Neuro-2A cells were transfected with the wt or ORF2 constructs.  At 48 hours 
after transfection, cells were collected and processed for Western blot analysis as 
described in the materials and methods. Closed circles denote wt ORF2 specific high 
molecular weight bands.  The position of ORF2, ORF2-P, and ORF2-AP specific 
proteins is also denoted.  100 µg of protein from the indicated fraction was loaded unto 
each lane. Cdk2 was used as a control for a protein residing in the nucleus.  
Panel C:  Precise amounts of protein from the different fractions were loaded into two 
different gels as described in panel A. One gel was processed for western blotting, the 
other for silver staining. Band density in each lane was quantified using a Bio-Rad 
molecular imager FX. The density of the respective bands in the western blot was divided 
by the density of bands in the appropriate lanes on the silver stained gel.  The graph is a 
representative of three independent experiments. 
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Figure 4.3:  ORF2 interacts with DNA following extraction from transfected Neuro-
2A cells 
Neuro-2A cells (5 x 10
6
) were transfected with plasmids expressing wt ORF2 (Panel A), 
ORF2-AP (Panel B), or ORF2-P (Panel C).  DNA chromatography was performed as 
described in the materials and methods with ss-DNA, ds-DNA, or blank cellulose beads.  
As a negative control, Neuro-2A cells were mock transfected.  One mg of ORF2 
expressing cell extract, or mocked transfected cell extract (Panel A), 300 μg of extract 
prepared from ORF2-AP (Panel B) or ORF2-P (Panel C) was used.  Lower 
concentrations of cell extract were used after transfection with ORF2-AP or ORF2-P 
because these plasmids express higher levels of ORF2.  Input (I) equivalent to 10% cell 
extract used in the experiments was loaded in the respective panels to verify that ORF2 
was expressed.  Expression of wt or mutant ORF2 in Neuro-2A cells was analyzed by 
Western blots using an anti-Flag antibody.  The open circle denotes ORF2 or ORF2 
mutant specific bands.  Molecular weight standards are shown on the left of each panel. 
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CHAPTER V 
 
Effect of LR gene expression on autophagy  
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ABSTRACT 
 
 Autophagy is a catabolic process involving the degradation of a cell’s own 
components through the lysosomal machinery. It is a tightly regulated process that plays 
an essential part in cell growth, development, and homeostasis. Autophagy helps to 
maintain a balance between the synthesis, degradation, and subsequent recycling of 
cellular long-lived proteins and organelles in the cytosol. Because of its essential role in 
maintaining cellular homeostasis, autophagy has been implicated in several diseases 
including cancer, neurodegeneration, and myopathies. Recent studies have described 
autophagy as a defense mechanism against intracellular viruses and bacteria because it 
can deliver whole microorganisms to lysosomes or it can deliver nucleic acids and 
antigens from the pathogen to endo/lysosomal compartments for activation of innate and 
adaptive immunity. On the other hand, autophagy is also exploited by certain viruses to 
enhance viral replication. The alpha-herpesvirinae subfamily member, HSV-1, inhibits 
autophagy as a function of its virulence. A recent study also showed that infection of 
bovine kidney cells with a BHV-1 bICP0 null mutant induces the accumulation of 
autophagosomes in the cytoplasm of infected cells. This suggests BHV-1 must employ a 
mechanism of evasion of autophagy in order to establish a successful infection. In this 
study, we examined the effect that expression of the LR gene has on autophagy.  The 
rationale for testing the LR gene is that previous studies demonstrated that the LR gene 
promotes cell survival, which enhances latency, which implied the LR gene influences 
autophagy.  Starvation of Hek293 cells led to efficient induction of autophagy as 
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determined by autophagy markers. However, the LR gene had no obvious effect on 
autophagy.   
149 
 
INTRODUCTION 
 
 Autophagy is a cellular process that leads to the lysosomal degradation and 
recycling of aberrant proteins or damaged organelles (Levine 2005; Levine et al. 2004; 
Reggiori 2006). This process is quite distinct from endocytosis-mediated lysosomal 
degradation of extracellular and plasma membrane proteins. Autophagy is mediated by a 
unique organelle called the autophagosome, which has been observed in all eukaryotes, 
plants, yeasts and animals.  Since autophagosomes function by engulfing portions of the 
cytosol, it is defined as a non-selective degradation system.  Originally identified as a 
process induced by cellular starvation, autophagy is now believed to be a cellular reaction 
to a variety of stimuli including environmental stresses and pathogen infection (Orvedahl 
et al. 2008).  
 
Increasing evidence suggests that autophagy plays a role in activation of innate 
and adaptive immunity (Levine et al. 2007). First, numerous studies (Dengjel et al. 2005; 
Nimmerjahn et al. 2003; Paludan et al. 2005; Schmid et al. 2007) have brought forward 
evidence that autophagy can deliver cytosolic antigen for MHC class II presentation. 
Second, by sequestering large portions of the cytoplasm in its double membrane 
structures, which ultimately delivers the contents to the lysosome, autophagy has the 
ability to target for degradation whole cellular pathogens (xenophagy) (Levine 2005). 
The best characterized examples of xenophagy are engulfment of Mycobacterium 
tuberculosis in phagosomes (Gutierrez et al. 2004), trapping of group A Streptococci in 
autophagosomes (Nakagawa et al. 2004), and immune escape by Shigella (Ogawa et al. 
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2005). Pathogens targeted by autophagy can also include DNA and RNA viruses like 
herpes simplex virus (Talloczy et al. 2006) and Sindbis virus (Liang et al. 1998). On the 
other hand, viruses employ their own mechanisms to evade or subvert autophagy 
(Kirkegaard et al. 2004; Orvedahl et al. 2007). RNA viruses like members of the 
Picornaviridae family have acquired mechanisms of subversion in order to utilize 
autophagy for their own benefit. Studies conducted with Poliovirus (Jackson et al. 2005), 
Enterovirus 71 (Huang et al. 2009) and Hepatitis C virus (Ait-Goughoulte et al. 2008; 
Dreux et al. 2009; Mizui et al. 2009) point to induction of autophagy in order to generate 
membranous vesicles or scaffolds crucial for viral RNA replication.  
 
Perhaps the most compelling evidence of viral evasion of autophagy comes from 
studies with herpes simplex virus type 1 (HSV-1). HSV-1 infection induces autophagy 
and infected cells are able to degrade HSV-1 through xenophagy (Talloczy et al. 2006). 
HSV-1 counteracts the induction of xenophagy through a neurovirulence protein, 
ICP34.5. ICP34.5 binds protein phosphatase 1 alpha to counter PKR-mediated 
phosphorylation of eIF2alpha, and also binds the autophagy-promoting protein Beclin 1 
(Orvedahl et al. 2007; Talloczy et al. 2002). Through these interactions, ICP34.5 
prevents translational arrest and down-regulates the formation of autophagosomes.  
 
A recent study in our lab provided evidence that infection of bovine kidney cells 
with bICP0 null mutant BHV-1 also induces autophagy (Geiser et al. 2008). 
Autophagosomes were not induced during infection of cells with a wt BHV-1 strain 
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suggesting that bICP0 may play a role in BHV-1 autophagy evasion.  Conversely, 
activation of other viral proteins may influence autophagy. 
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RESULTS AND DISCUSSION 
 
Effect of LR protein on autophagy 
 HSV-1 inhibits autophagy in infected cells mainly through its neurovirulence 
protein ICP34.5 (Orvedahl et al. 2007; Talloczy et al. 2002). BHV-1 which is also an 
alpha-herpesvirinae subfamily member does not encode a known ICP34.5 homologue. 
The locus of ICP34.5 in the HSV-1 genome lies between ICP0 and ICP4 genes and it is 
transcribed anti-sense with respect to LAT. In the BHV-1 genome bICP0 and bICP4 are 
not separated like HSV-1. They are however transcribed anti-sense to the LR gene similar 
to LAT for HSV-1. To test whether this region of the BHV-1 genome expressed products 
that could have an effect on autophagy we expressed the full LR gene including its 
noncoding promoter region in Hek293 cells under starvation conditions that induce 
autophagy.  
One of the hallmarks of autophagy is the change in subcellular localization of the 
microtubule-associated protein light chain 3 (LC3) (Klionsky et al. 2008). Normally LC3 
is localized in a diffused manner throughout the cytoplasm. During induction of 
autophagy, through a series of proteolytic and covalent modifications involving an 
ubiquitin-like conjugation system the C-terminus tail of LC3 is cleaved and a 
phosphatidylethanolamine group is subsequently added to LC3 (Ohsumi 2001). This 
allows LC3 to become embedded into the membrane of autophagic vesicles and its 
localization changes from diffused to punctated.  
 To test autophagy induction, Hek293 cells expressing LC3 N-terminally fused 
with a green fluorescent protein (GFP) or GFP alone as a negative control, were starved 
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for 10 hours in HBSS buffer. When cells expressing only GFP were observed using 
fluorescence microscopy, the localization of GFP as expected was diffuse throughout 
cells under normal or starvation conditions (Figure 5.1.A). LR expression also had no 
effect on the localization of wt GFP (Figure 5.1.A). In cells expressing LC3 N-terminally 
tagged with GFP under normal growth conditions, the LC3-GFP localization was 
diffused throughout the cell (Figure 5.1.B). The localization became punctated however, 
when cells were starved in HBSS indicating induction of autophagy (Figure 5.1.B). 
Expression of LR gene products did not however seem to inhibit the punctated 
localization of LC3-GFP when autophagy was induced through HBSS starvation (Figure 
5.1.B). 
 
 Since the transformation of LC3 during autophagy involves cleavage of its C-
terminal tail, two species of LC3 with different molecular weights are produced. Normal 
LC3 (LC3 I) migrates as an 18 kDa protein while the cleaved species (LC3 II) migrates 
with an apparent molecular weight of 16 kDa. The difference can be distinguished by 
Western blotting. To test the effect of LR on autophagy, Hek293 cells co-expressing 
LC3-GFP with a vector control or LR gene expressing plasmid, were starved for 10 hours 
in HBSS buffer and total proteins extracted and subjected to western blot analysis.  LC3 
proteins were detected with an anti-GFP antibody. The antibody recognized a band 
around 45 kDa which represents GFP-LC3 I (GFP is ~27 kDa). When cells were treated 
with HBSS, another species at around 43 kDa was detected representing GFP-LC3 II. 
There was no effect on the amount of LC3-GFP cleavage when the LR gene was 
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expressed. In summary, these results indicated that LR gene products have no obvious 
effects on autophagy. 
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FIGURES 
 
Figure 5.1: Effect of LR gene expression of autophagy 
Hek293 cells were co-transfected with either a control plasmid or a plasmid expressing 
the full LR gene under its natural promoter and a CMV-promoter plasmid expressing 
GFP (Panel A) or LC3-GFP (Panel B). Twenty four hours after transfection cells were 
either incubated in normal 10% FCS MEM media (Media) or were starved in HBSS 
buffer (HBSS) for 10 hours. Cells were then visualized with a fluorescent microscope 
(Panels A and B) or processed for western blot analysis (Panel C). Mouse Anti-GFP 
antibody was used to detect LC3-GFP in the western blot. LC3 I indicates the position of 
GFP-LC3 I and LC3 II indicates the position of the cleaved species GFP-LC3 II. An 
asterisk denotes degradation products.  
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GENERAL CONCLUSIONS 
 
The overall goal of the work presented in this dissertation was aimed at further 
elucidating, at the molecular level, the BHV-1 latency-reactivation process. Although 
immense effort has been focused toward understanding how alpha-herpesviruses 
establish, maintain and escape from latency, significant gaps in our knowledge still 
remain. The molecular mechanisms involved in the establishment of latency are of 
considerable importance in the fight to prevent recurrent disease and transmission.   
 
The lytic and latent phases of BHV-1 lifecycle contrast from one another in 
overall gene expression and virus production. During the lytic phase, all viral genes are 
abundantly expressed and virus progeny is produced at high yields. During the latent 
phase, viral gene expression is not readily detectable with the exception of the LR gene 
and no virus can be detected. Genetic studies indicated that a protein (s) encoded by the 
LR gene is/are required for dexamethasone induced reactivation from latency in calves.  
Additional studies demonstrated  that LR gene products promote latency by a least two 
ways; repressing lytic cycle viral gene expression (Bratanich et al. 1992; Geiser et al. 
2002; Jaber et al. 2010) and inhibiting apoptosis in latently infected neurons through the 
expression of ORF2 (Ciacci-Zanella et al. 1999; Henderson et al. 2004; Lovato et al. 
2003; Shen et al. 2008; Sinani et al. 2011). In addition to inhibiting apoptosis, ORF2 
interacts with at least three cellular transcription factors: C/EBP-alpha, Notch1, and 
Notch3 (Meyer et al. 2007; Workman et al. 2011). Furthermore, Notch signaling 
enhances expression of certain viral promoters and productive infection (Workman et al. 
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2011). ORF2 inhibition of Notch suggests that this protein affects viral and/or cellular 
transcription and perhaps other functions necessary for the latency-reactivation cycle. 
Thus, identifying functional domains in ORF2 is important in trying to understand how 
ORF2 regulates the BHV-1 latency-reactivation cycle.  For this study, we used a 
mutational analysis approach. An examination of the ORF2 sequence identified a NLS 
that matches the NLS in the cellular transcription factor Sp1 (Devireddy et al. 2003) and 
several putative phosphorylation sites. Deletion of the NLS (ORF2-∆NLS) prevented 
localization of this mutant to the nucleus but had no effect on inhibiting apoptosis 
suggesting that nuclear localization of ORF2 was not required for its anti-apoptosis 
functions. However, ORF2-∆NLS was unable to inhibit Notch activation of BHV-1 
bICP0 early promoter and productive infection. Mutating all of the putative 
phosphorylation sites within ORF2 or just the consensus PKA/PKC phosphorylation sites 
led to increased levels of ORF2 in neuro-2A cells but had no effect on inhibiting 
apoptosis or Notch1 activation of BHV-1 promoters and productive infection.  The 
presence of PKA phosphorylation sites in ORF2 has a potential biological significance 
because cAMP, which activates PKA (Das et al. 2007), stimulates HSV-1 reactivation 
from latency suggesting phosphorylation of ORF2 could play a similar role (Leib et al. 
1991; Smith et al. 1992). The lack of known functional domains in ORF2 prompted us to 
use a random-transposon insertion system where a transposon linker is randomly inserted 
throughout the gene with the intent of disrupting any putative functional domains. 
Analysis of the function of the transposon mutants revealed that ORF2 contains two non-
overlapping functional domains with the N-terminus being important for inhibiting 
Notch1 mediated trans-activation of productive infection and the C-terminus playing a 
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role in the inhibition of apoptosis.  
 
Additional studies were performed to test whether ORF2 influenced the ability of 
Notch to regulate known cellular functions. To test this hypothesis, we examined whether 
Notch signaling influences neurite formation, which is crucial for normal neuronal 
functions (Franklin et al. 1999; Levy et al. 2002). Previous studies have shown that 
Notch1 and Notch3 inhibit neurite formation in serum-arrested Neuro-2A cells 
(Berezovska et al. 1999; Franklin et al. 1999; Levy et al. 2002; Sestan et al. 1999). When 
we overexpressed ORF2 in the presence of Notch1 or Notch3, neurite growth in Neuro-
2A cells was restored.  Many other genes, in addition to Notch, negatively regulate 
neurite sprouting.  HES1 and HES5 are two Notch target genes that inhibit neurite 
sprouting and neuronal differentiation (Ohtsuka et al. 1999). Both Notch1 and Notch3 
strongly activate HES-5 promoter activity.  Additional studies demonstrated that ORF2 
inhibits HES5 activation by both Notch1 and Notch3. The N-terminal domain of ORF2 
was important in restoring neurite formation in the presence of Notch. However it seemed 
that ORF2 phosphorylation was necessary for inhibiting Notch mediated activation of the 
HES5 promoter. This suggests multiple layers of interaction of ORF2 with Notch 
signaling. For activated Notch to stimulate transcription, Notch, CSL, and MAML must 
form a complex at a consensus CSL binding site (Bray 2006; Ehebauer et al. 2006).  
Consequently, ORF2 may: 1) interfere with the formation of the Notch/CSL/MAML 
complex, 2) influence the Notch/CSL/MAML complex from interacting with certain CSL 
consensus binding sites, or 3) interfere with certain co-activators recruited to the Notch-
CSL-MAML complex, (Bray 2006; Ehebauer et al. 2006). The finding that ORF2 
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reduced the steady state levels of Notch3 adds to our understanding of how ORF2 
controls the trans-activation potential of Notch. Interestingly, ORF2 phosphorylation 
state influenced Notch trans-activation of the bICP0 early promoter but not the HES5 
promoter. 
   
The published results suggest that ORF2 promotes survival of infected neurons by 
at least two distinct mechanisms: 1) inhibiting apoptosis (Meyer et al. 2007; Shen et al. 
2008; Workman et al. 2011) and 2) interfering with viral transcription by sequestering 
cellular transcription factors such as Notch1, Notch3 (Workman et al. 2011), and/or 
C/EBP-alpha (Meyer et al. 2007). Anti-apoptosis functions of ORF2 are crucial for the 
latency-reactivation cycle because a LR mutant virus that contains stop codons at the 
amino-terminus of ORF2 induces higher levels of apoptosis in TG neurons during 
establishment of latency (Lovato et al. 2003) and does not reactivate from latency after 
dexamethasone treatment (Inman et al. 2002). The ability of ORF2 or an ORF2 fusion 
protein to interact with cellular transcription factors that stimulate productive infection 
would promote the establishment and/or maintenance of latency. C/EBP-alpha is induced 
during dexamethasone-mediated reactivation from latency (Meyer et al. 2007) and 
cooperates with bTIF, the HSV-1 VP16 homologue, to trans-activate the immediate early 
transcription unit 1 promoter (Meyer et al. 2008). Concurrently, through interactions with 
the Notch pathway, ORF2 promotes “neuronal health” during life-long latency. For 
example, BHV-1 productive infection induces Notch1 protein levels (Workman et al. 
2011) suggesting that during the establishment of latency ORF2 ensures that infected 
neurons maintain axonal projections by promoting neurite sprouting in the presence of 
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activated Notch.  In the absence of ORF2 (LR mutant virus for example), we predict that 
certain infected neurons are more susceptible to loss of axonal projections because 
activated Notch is present.  It is well established that neurons in which their axons have 
been damaged or cut can undergo Wallerian degeneration, a slow form of neuronal death 
suggesting that ORF2 may protect infected and damaged neurons from Wallerian cell 
death (Coleman et al. 2010; Robertson et al. 1995). ORF2 may also sequester Notch1 and 
Notch3 to regulate steps that are necessary for establishing or maintaining life-long 
latency in cattle. Since Notch1 and Notch3 RNA and protein levels are increased in 
trigeminal ganglia during reactivation after dexamethasone treatment leading to 
activation of BHV-1 promoters and enhancement of productive infection (Workman et al. 
2011), inhibition of Notch by ORF2 may be crucial for maintenance of latency by 
preventing reactivation. However, ORF2 may not be the only important product encoded 
by the LR gene because other proteins are encoded by the LR gene (Inman et al. 2004; 
Meyer et al. 2007) and two micro-RNAs encoded by the LR gene reduce bICP0 protein 
levels (Jaber et al. 2010).  
 
  In addition to inhibiting apoptosis and Notch signaling, we have also provided 
evidence that ORF2, in the absence of other viral proteins, stably associates with DNA 
preferentially interacting with ss-DNA. Mutation of phosphorylation sites strongly 
enhanced the ability of ORF2 to interact with ds-DNA, which was similar to ORF2 
purified from bacteria under denaturing conditions. These results suggested that 
conformation and/or the charge of ORF2 influence its ability to interact with ds- versus 
ss-DNA. 
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A 29 amino acid motif in the N-terminus of ORF2 that spans the region around 
the NLS, is similar to two cellular transcription factors that specifically bind DNA (Sp5 
and Sp8) suggesting that ORF2 specifically binds DNA. So far we have no evidence that 
ORF2 binds to a specific DNA sequence. It is however possible that ORF2 can bind 
specific DNA sequences in the presence of a neuronal factor or by specific post-
translational modifications. It is also possible that ORF2 could preferentially bind a 
broad-based consensus sequence that is frequently present in the viral genome. 
 
The finding that ORF2 is tightly associated to the nuclear periphery in transiently 
transfected cells (Sinani et al. 2011; Workman et al. 2011) and that ORF2 interacts with 
ss- and ds-DNA implies that ORF2 recruits the viral genome to certain sub-nuclear 
structures in latently infected neurons.  Several studies have concluded that if genes are 
localized to the nuclear periphery or nuclear envelope gene expression is reduced or 
silenced (Finlan et al. 2008; Green et al. 2012; Shaklai et al. 2007; Vande Vosse et al. 
2011).  Conversely, the organization of genes at the nuclear periphery or nuclear 
envelope can also lead to activation depending on factors located at these respective 
specific sites (Akhtar et al. 2007). If ORF2 recruits viral genomes to the nuclear 
periphery, this could prevent viral genomes from entering replication compartments in 
infected sensory neurons and consequently promote the establishment and/or the 
maintenance of latency.  Since ORF2 does not regulate basal levels of several BHV-1 
promoters tested (Sinani et al. 2011; Workman et al. 2011), this suggests that ORF2 is 
not a sequence-specific repressor of transcription. Our studies suggest that most likely 
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ORF2 regulates gene expression by sequestering specific cellular transcription factors, 
and this function does not appear to require sequence specific binding of ORF2 to DNA.  
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